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Protein degradation is an essential cellular process that helps maintain 
proper homeostasis. The ClpXP protease broadly regulates bacterial 
development and quality control during the cell cycle. The range and order of 
substrates that ClpXP degrades during the cell cycle is dictated by 3 accessory 
proteins, which are known as adaptors. This thesis will elaborate on how 
dimerization tightly regulates the stability and activity of the adaptor protein at the 
center of this hierarchy, RcdA, and show how this affects normal cellular 
processes in Caulobacter crescentus. I will discuss the mechanism by which 
dimerization limits RcdA activity and how the dimerization interface contains 
selective regions that differentiate which substrates can engage with RcdA. 
Lastly, I will discuss how RcdA and the master regulator of Caulobacter, CtrA, 
interacts with the third adaptor in the hierarchy, PopA and the various surfaces 
on the PopA adaptor that are involved in each interaction. The remainder of the 
thesis will present data that arises from these projects. 
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An Overview of Adaptor-Dependent Protein Degradation and Regulation 
 
Parts of this introduction were as written by Kuhlmann, N.J. and Chien, P.,  
published in Current Opinions in Microbiology 2017 
 
 
1.1  Overview 
The controlled degradation of proteins is a necessity for cellular development and 
physiology. AAA+ (ATPases Associated with diverse cellular Activities) proteases 
dictate the lifetime of proteins after translation, offering another layer of post-
translational control and recycling amino acids for metabolic networks in all 
organisms. While there are few proteases in every organism, they contain the 
capacity to completely change the balance of proteins in the cell at any given 
point. In most cases, proteases themselves are also tightly regulated by 
additional factors, be it small molecules, protein scaffolds, post-translational 
modifications, or even degradation by themselves or other proteases. At the 
center of my thesis is the question of how protein scaffolds, or adaptors regulate 
which substrates are chosen to be degraded at the molecular level and how 
degradation of adaptors affects cell physiology. I will go into detail into different 
proteases that use adaptors to regulate their mechanism and substrate selection, 
how adaptors can work in tandem to regulate substrate selection in a hierarchical 
manner, how adaptors themselves are regulated post-translationally, and the 
specific characteristics of my adaptor of focus, RcdA. Each of these topics drive 




1.2  Adaptor-Dependent Proteases in Nature 
Proteases are, on the surface, simple enzymes. Proteases typically consist of 
two functional components: the unfoldase domain, which recognizes folded or 
unfolded substrates by a short sequence motif, called a degron. After recognition 
of this sequence, the AAA+ unfoldase module unravels the substrate through the 
power of ATP hydrolysis into its primary structure, where the substrate is fed into 
the proteolytic peptidase module (Figure 1.1), (Hanson and Whiteheart, 2005).  
The unfoldase module is therefore responsible for the initial specificity of the 
protease-substrate interaction. However, during specific stages of the cell-cycle 
and during periods of stress, additional levels of specificity are needed to prevent 
unwanted degradation and to prioritize certain substrates. In such cases, 
proteases use additional proteins called adaptors to dictate substrate selection. 
At the simplest level, a protease adaptor acts to select which substrates are 
actively engaged with the unfoldase component of a protease (Figure 1.2). 
Proteases that use adaptors are widespread in nature. The ClpXP protease, 
found in bacteria and in human mitochondria (Baker and Sauer, 2011), makes 
use of several adaptors to drive cell-cycle dependent protein degradation, the 
function of which I will go into greater detail in section 1.4. For the Clp family of 
proteases, there are several proteases that make use of specific adaptors to 
regulate substrate choice. The ClpAP protease, which shares similarities to 
ClpXP, uses the ClpS adaptor to prioritize N-end rule substrates (Erbse et al, 




protease uses several adaptors, MecA, McsB, and YpbH, to regulate the 
competency and sporulation of the bacterium by degrading factors such as 
ComK and ComS (Schlothauer et al, 2003, Persuh et al, 2002, Kirstein et al, 
2007). Interestingly, the assembly of the ClpC hexameric unfoldase is mediated 
by interactions with MecA, suggesting that adaptors can act in other ways 
besides direct substrate engagement to regulate protease function (Kirstein et al, 
2006). Finally, the 26S proteasome uses adaptors such as Cic1 to recruit specific 
proteins for proteasomal degradation (Jager et al., 2001). In each of these cases, 
adaptors provide an additional layer of specificity and prioritization for the 
protease substrate pool such that substrates of particular importance are 
selectively degraded. For some adaptors such as MecA, the post-translational 
state of the adaptor is modified by phosphorylation to control its function and this 
has direct consequences on the physiology and development of the bacteria. The 
additional layers of regulation that gate adaptor activity and stability is a central 





Figure 1.1: Mechanism of Protease Function.  
AAA+ Proteases contain two functional modules: A hexameric unfoldase 
chaperone, and a peptidase chamber that contains the proteolytic active site. 
Through the power of ATP hydrolysis, the unfoldase portion engages substrates 
through a short sequence recognition motif, then unfolds the substrate into the 













Figure 1.2: Mechanism of Protease Adaptors.  
Adaptor proteins work by limiting the protease to only degrading certain targets, 
providing extra levels specificity to the substrate-unfoldase interaction. Many 
adaptors interact with the substrates to bring them in proximity of the unfoldase, 












1.3 Specific Adaptors Tether or Prime Proteases for Delivery of Cargo 
Parts of this section were taken from Kuhlmann, Chien 2017.  
Adaptors typically fall into two modes of function: that of an active primer or that 
of a passive scaffold. Adaptors that act as active primers prepare the protease 
for substrate delivery, often by directly interacting with the protease before 
interacting and delivering its cargo. In the case of the CpdR adaptor 
from Caulobacter crescentus, binding of this protein to the unique N-domain of 
the ClpX unfoldase prepares the protease for recognition of a class of substrates 
(Figure 1.3), (Lau et al., 2015, Iniesta et al., 2006). Here, the adaptor does not 
strongly interact with its cargo in the absence of the ClpX N-domain. This 
preparation, or priming, of the protease could arise from conformational changes 
in either CpdR or ClpX upon adaptor binding or could stem from a composite 
interaction surface that is only present in the complex. Regardless of mechanism, 
this type of priming function has features distinguishable from a simple scaffold. 
For example, high concentrations of scaffolds such as SspB inhibit substrate 
degradation because partial occupancy of the scaffold restricts simultaneous 
binding of substrate and protease. By contrast, CpdR activity resists such 
inhibition as the substrate binding activity is only present when the adaptor binds 
the protease (Lau et al., 2015). 
Similar types of priming functions have been observed with other adaptor 
systems. Binding of the YjbH adaptor is required for Spx degradation by ClpXP in 




binding unveils a C-terminal degron in Spx that is in turn recognized by ClpXP 
(Chan et al, 2014). The RssB adaptor binds RpoS directly, but its weak binding to 
ClpX suggests that priming of the substrate by the adaptor is needed for 
protease recognition (Zhou et al., 2001, Studemann et al., 2003). Thus, it seems 
that the ability of adaptors to activate either protease or substrate for eventual 










Figure 1.3: Mechanism of the Priming Adaptor CpdR.  
The CpdR adaptors acts a primer for the ClpXP protease. CpdR does not interact 
with its substrates on its own, rather, it directly interacts with the N-terminal 
domain of ClpX to prime ClpX for interactions with CpdR-dependent substrates. 
While the mechanism of CpdR-dependent ClpX activation is currently unknown, 
this mechanism might involve the formation of a new composite interface 















The simplest mechanism for an adaptor is that of a passive scaffold. In these 
cases, the adaptor directly interacts with its cargo outside of the presence of a 
protease and increases the effective concentration of substrate that the 
unfoldase module encounters. In doing so, the adaptor increases the relative 
concentration of substrates to well past the KM of the protease by constraining the 
volume of the substrate to make recognition events by the unfoldase module 
happen more frequently. Adaptors that follow this function are the SspB adaptor, 
which binds and delivers substrates tagged with the ssrA peptide appended to 
proteins arising from failed translation events (Levchenko et al., 2000, Gottesman 
et al., 1998). SspB acts as a constitutive adaptor as its levels are constant 
throughout the bacterial life cycle (Farrell et al., 2005). Other adaptors that follow 
this mechanism are ClpS (Erbse et al, 2006, Wang et al, 2007 and 2008), and 
the RcdA (Regulator of CtrA Degradation) adaptor in Caulobacter crescentus 
(Figure 1.4), (Joshi et al., 2015, McGrath et al, 2006), the adaptor of my research 
focus in my thesis. In the next subchapter, I will go into the specific functions that 
RcdA performs during the Caulobacter cell-cycle and how it coordinates its 







Figure 1.4: Mechanism of the Scaffolding Adaptor RcdA.  
The RcdA adaptor acts as a scaffold for CpdR and ClpXP. RcdA directly binds its 
cargo, and upon interactions with a CpdR-primed ClpXP, can scaffold its 
substrates to ClpX for unfolding and subsequent degradation. RcdA’s function as 
a scaffold increases the relative substrate concentration by constraining the 
volume that the pool of substrate occupies, allowing for ClpX to encounter a 
higher effective concentration of substrate and consequentially result in more 







1.4  A Hierarchy of Adaptors Drive Cell-Cycle Protein Degradation in 
Caulobacter crescentus 
Proteases make use of adaptors during cellular transitions and during times of 
stress. In Caulobacter crescentus, the ClpXP protease makes uses of a 
hierarchy of adaptor proteins to dictate substrate degradation during the 
developmental transition from a motile swarmer developmental state to a sessile 
stalked developmental state. During the G1 to S transition in the Caulobacter life 
cycle, ClpXP degrades a series of key regulatory proteins that include 
chemoreceptors involved in cell motility (Bhat et al., 2013, Tsai et al., 2001) and 
several replication and transcription factors critical for promoting proper cell cycle 
and developmental control (Quon et al., 1996, Gora et al., 2013, Biondi et al., 
2006, Gorbatyuk et al, 2005). While the ClpXP is capable of degrading important 
cell cycle independent substrates such as DnaX (Vass et al., 2013), ClpXP 
requires one or more adaptors for all substrates that are degraded in a cell-cycle 
dependent manner (Bhat et al., 2013, Joshi et al, 2015, Lau et al., 2015). During 
the Caulobacter cell-cycle, ClpXP makes use of 3 adaptors and oscillating levels 
of the small molecule cyclic-di-GMP (cdG) to dictate which substrates are 
degraded (Figure 1.5). During G1, the first adaptor, CpdR, binds to the N-
terminal domain of ClpX, allowing the degradation of a class of substrates 
specific to CpdR, including the phosphodiesterase PdeA, which downregulates 
the levels of cdG (Lau et al., 2015).  Only after CpdR is assembled on ClpXP can 




of substrates that includes the σ54 transcription factor TacA, which is involved 
regulating genes involved in stalk biogenesis (Biondi et al., 2006, Joshi et al., 
2015), and the pole-localized protein SpbR, which is implicated in inhibiting 
centromere translocation (Wang et al., 2019). After the assembly of CpdR and 
RcdA onto ClpX, the third adaptor, PopA (Duerig et al., 2009, Ozaki et al., 2014), 
binds the small molecule cdG and RcdA to deliver its own class of substrates, 
which include the replication inhibitor CtrA (Quon et al., 1996, Smith et al., 2014). 
This hierarchical proteolysis provides precise timings of degradation coupled to 
the tight regulation of cdG levels to provide several layers of regulation of this 
important signaling pathway in Caulobacter. The use of several adaptors appears 
to be present in Eukaryotic organelles as well, as the ClpF and ClpS1 adaptor 
complex is necessary for the regulated degradation of GluTR, a critical enzyme 
involved in tetrapyrrole synthesis in chloroplasts (Nishimura et al., 2015). The 
presence of several multi-adaptor systems indicates the necessity for various 
levels of regulation when delivering key protein targets, suggesting that other 
proteolytic machines may have these adaptor hierarchies in place that as of yet 
unknown. At the center of the Caulobacter adaptor hierarchy is RcdA, which 
coordinates binding between CpdR, PopA and the range of cargo it delivers to 
ClpXP. The broad focus of my thesis is understanding how RcdA and other 
adaptors in this pathway function mechanistically. In the following subchapters, I 
will go into detail into how RcdA degradation (Joshi et al., 2017) and RcdA 




2015) are fundamental properties that drive the major research questions of my 







Figure 1.5: An Adaptor Hierarchy Controls Cell-Cycle Protein Degradation 
in Caulobacter 
A series of adaptors controls cell-cycle degradation in Caulobacter. The 
developmental transition from a motile swarmer cell in G1 to a sessile stalked cell 
during the onset of S-phase and DNA replication is regulating by adaptor-
dependent protein degradation. The first adaptor, CpdR, binds ClpX and delivers 
a class of substrates. The second adaptor, RcdA, binds to a CpdR-primed ClpX 
and delivers its class of substrates. Finally, the third adaptor, PopA, binds the 
small molecule cdG and RcdA, facilitates the degradation of CtrA, and DNA 














1.5  Adaptors are Broadly Degraded in the Absence of Cargo 
A critical conundrum exists for adaptors: what happens after they perform their 
delivery jobs? While not actively delivering cargo, many of these adaptors run the 
risk of being degraded by their respective proteases (Figure 1.6). Experimental 
evidence has shown that adaptors like MecA and HspQ themselves are 
degraded by their respective proteases, suggesting that adaptor degradation is a 
broadly conserved phenomenon (Puri et al., 2017, Turgay et al., 1998). In 
Caulobacter, Previous studies have shown that several ClpXP adaptors in 
Caulobacter, including RcdA, SspB and CpdR are specifically degraded by 
ClpXP (Joshi et al., 2017). Surprisingly, PopA does not appear to be degraded by 
ClpXP despite CpdR and RcdA being substrates for the protease. Interestingly, 
RcdA is stabilized in the presence of cargo and only appears to be degraded 
when there is not cargo present (Joshi et al., 2017). Nondegradable variants of 
RcdA substrates, such as TacADD and SpbRDD, are sufficient to protect RcdA 
from degradation, suggesting that the act of RcdA binding to cargo itself is 
responsible for this protection. The precise mechanism for this phenomenon is 
unknown, as it appears that only native degradation tags cause this stabilization 
(Joshi et al., 2017). My thesis work will provide an explanation for how cargo 








































Figure 1.6: Adaptors are Degraded by their Proteases 
Adaptors run the risk of degradation in the absence of cargo. In the case of the 
ClpXP adaptor hierarchy, adaptors are protected from degradation while 
delivering cargo (right cartoon). Because each adaptor physically interacts with 
parts of the protease, the degradation motif is near ClpX. Binding of cargo 

















1.6 RcdA Dimerization and Cargo Binding Characteristics 
In this section, I will go into detail about the history of experimental 
characterization of RcdA to give context into the research questions I explore in 
my thesis work. RcdA was discovered by mining previously published genomic 
datasets to find gene candidates that potentially regulate CtrA function (McGrath 
et al., 2006). Deletion of the RcdA gene from the Caulobacter genome leads to 
stabilization of CtrA during the cell cycle, improper stalk formation and cell 
motility on swarm agar, and a G1 cell cycle arrest when CtrA is not being 
redundantly controlled by phosphorylation (McGrath et al., 2006). In 2009, RcdA 
was crystallized and biochemically characterized in solution as a homodimer with 
a disordered C-terminal tail, removal of which results in the inability to deliver 
CtrA (Taylor et al., 2009). The dimer interface of RcdA (Figure 1.7) is broad and 
covers many conserved hydrophobic and charged residues which I will explore in 
detail in chapter 2. Following the work from Taylor et al., detailed characterization 
of RcdA was performed to determine how RcdA regulates ClpXP substrate 
degradation during the cell cycle (Joshi et al., 2015). In this work, an affinity 
pulldown mass-spectrometry approach was used to identify additional cargo of 
RcdA, revealing the breadth of cargo that RcdA interacts with (Figure 1.8, Joshi 
et al., 2015). In addition to binding CpdR and PopA, the other adaptors in the 
hierarchy, RcdA is capable of directly binding several cargo in solution, such as 
SpbR and TacA, and tether those cargo to a CpdR-primed ClpXP for degradation 




interact with its cargo, it is unclear how RcdA can accommodate such a wide 
range of cargo and whether RcdA dimerization plays a role in binding.  
 
 
Figure 1.7: Dimerization Interface and Structure of RcdA 
Two orientations of the published crystal structure of RcdA (PDB: 3ctw) with one 
subunit represented as a surface projection and the other subunit represented by 
a cartoon projection. The PDBePISA prediction of the dimer interface is 

















Figure 1.8: RcdA Binds a Range of Cargo 
RcdA functions by directly interacting with direct substrates, such as TacA and 
SpbR, and interacting with other adaptors such as PopA. To deliver cargo to 





1.7  Research Questions and Conclusions 
The broad, overarching questions that my thesis was designed to answer involve 
RcdA and its mechanism. First, how does RcdA interact with such a wide range 
of cargo? While we know that RcdA is responsible for delivering at least 3 cargo 
to ClpXP for degradation (Joshi et al., 2015), none of these cargoes share any 
obvious sequence or fold motifs that indicate a conserved module that RcdA 
recognizes. How does RcdA accomplish this task while also performing its critical 
cell cycle responsibilities? While performing its delivery tasks, RcdA must also 
have a functional mechanism to protect itself from degradation when bound to 
cargo. How does RcdA accomplish this task? It is clear from structural and 
biochemical data that RcdA forms a homodimer (Taylor et al., 2009). Does 
dimerization play an important role in RcdA function, or is RcdA dimerization 
simply an artifact of crystallization? More broadly, my thesis aims to answer how 
RcdA coordinates binding between the third adaptor, PopA, to regulate CtrA 
degradation. The work presented in this thesis will highlight new mechanisms by 
which adaptor proteins regulate the bacterial cell cycle and explore new ways to 
characterize adaptor function. However, the field of adaptors and scaffolds 
requires new tools and screens to identify new adaptors and adaptor-dependent 
substrates. For identifying new adaptors, it is more challenging. RcdA was 
originally identified as a regulator of CtrA degradation, and through serendipity, 
was discovered to be an adaptor for TacA degradation. Creative genetic and 




framework for adaptor discovery projects, as it seems clear that adaptor proteins 
play a critical role in regulating bacterial and organelle physiology. Advances in 
quantitative proteomics, combined with the ability to synchronize different cell 
populations of Caulobacter, will allow more rigorous and systematic identification 
of new adaptor-dependent substrates.  Generation of specific allelic mutations in 
adaptors that differentially affect specific classes of substrates and specific 
phenotypes will help identify new substrate candidates that can be validated 
biochemically or genetically by narrowing the available substrate pool.  
1.8 Thesis Structure 
The second chapter of this thesis will describe my work in elucidating the 
mechanism behind RcdA function and its biological significance. The third 
chapter will describe my work in identifying the surfaces on PopA that are 
involved in RcdA and CtrA interactions and degradation. The fourth chapter will 
discuss lessons I’ve learned from my thesis work and provide future directions for 
the field of protease adaptors. In the appendix I will provide any unpublished 
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Bacterial protein degradation is a regulated process aided by protease adaptors 
that alter specificity of energy dependent proteases. In Caulobacter crescentus, 
cell-cycle dependent protein degradation depends on a hierarchy of adaptors, such 
as the dimeric RcdA adaptor which binds multiple cargo and delivers substrates to 
the ClpXP protease. RcdA itself is degraded in the absence of cargo and how 
RcdA recognizes its targets is unknown. Here we show that RcdA dimerization and 
cargo binding compete for a common interface. Cargo binding separates RcdA 
dimers and a monomeric variant of RcdA fails to be degraded, suggesting that 
RcdA degradation is a result of self-delivery. Based on HDX-MS studies showing 
that different cargo rely on different regions of the dimerization interface, we 
generate RcdA variants that are selective for specific cargo and show cellular 
defects consistent with changes in selectivity. Finally, we show that masking of 
cargo binding by dimerization also limits substrate delivery to restrain overly prolific 
degradation.  Using the same interface for dimerization and cargo binding offers 
an ability to limit excess protease adaptors by self-degradation, while providing 










This chapter describes our effort to elucidate how RcdA engages its cargo. Initial 
studies showed that RcdA is a homodimer in solution and binds directly to its 
cargo using several biochemical assays, including size-exclusion 
chromatography (SEC) and fluorescence polarization (FP) experiments (Taylor et 
al., 2009, Joshi et al., 2015). Initial characterization of RcdA-cargo complexes by 
analytical SEC confirmed that RcdA binds it cargo, resulting in a higher molecular 
weight species (Figure 2.1). However, it remained unclear based on the 
uncertainty coming from the protein standards used in analytical SEC 
experiments what the exact stoichiometry between RcdA and its cargo was and 
whether this stoichiometry was consistent for all RcdA cargo. Our expectation, 
based on prior work with the dimeric ClpXP adaptor SspB showing that optimal 
delivery is achieved when two molecules of substrate are bound to a distal site 
on SspB (Chien et al., 2007, McGinness et al., 2007, Bolon et al., 2004), was that 
RcdA would share a similar mechanism. Due to the limitations of analytical SEC, 
we were worried that reported masses would be inaccurate due to the 
dependence on internal standards that do not consider protein shape, a common 
pitfall in analytical SEC experiments. We decided to use sensitive biophysical 
techniques that take absolute measurements of mass to fully characterize the 







Figure 2.1: RcdA Directly Interacts with its Cargo by Analytical SEC 
A) Analytical SEC of RcdA and SpbR. 25µM RcdA (black), 25µM SpbR alone 
(blue), or 25µM RcdA and SpbR together (red) were incubated for 45 
minutes and ran over a 3mL analytical SEC column.  B) Analytical SEC of 
RcdA and the DNA-binding domain of TacA (Joshi et al., 2015). 25µM RcdA 
(black), 25µM DBDTacA (blue) or 25µM RcdA and 25µM DBDTacA together 








2.3 RcdA Binds its Cargo as a Monomer 
We began our studies by exploring RcdA-cargo binding using size-exclusion 
chromatography with multi-angle light scattering (SEC-MALS) to measure 
absolute molar mass. SpbR, a RcdA-dependent cargo responsible for inhibiting 
centromere translocation (19) is a 42 kDa monomer in solution, while as expected, 
the molar mass of RcdA is a dimer (36 kDa, Figure 2.2). The combination of both 
proteins results in a complex with a determined mass of 61 kDa (Figure 2.2). Our 
data is consistent with a monomer of RcdA (17 kDa) binding a monomer of SpbR 
(44 kDa) and inconsistent with a dimer of RcdA binding a monomer of SpbR (a 
predicted mass of 77 kDa) (Table 1). We confirmed this monomer:monomer 
stoichiometry by using analytical ultracentrifugation and found a similar mass of 60 
kDa for the RcdA:SpbR complex (Figure 2.3).  
We next tested other RcdA cargo. PopA, the RcdA-binding adaptor, shows an 
experimental mass of 41 kDa (Figure 2.2). In the presence of RcdA, the complex 
mass is 58 kDa consistent with a monomer of PopA (41 kDa) binding a monomer 
of RcdA (17 kDa) (Figure 2.2; Table 1). TacA, a transcription factor involved in 
stalk biogenesis, has an experimental molar mass consistent with a dimer (124 
kDa). When bound to RcdA, the complex shows an apparent mass of 141 kDa, 








Figure 2.2: RcdA forms a Monomer when Bound to Cargo by SEC-MALS 
A) SEC-MALS traces of different RcdA-cargo complexes. Representative SEC-
MALS traces of the RcdA, cargo, and the RcdA-cargo complexes.  Left axes show 
normalized absorbance traces, right axes show calculated molecular weight in 
kilodaltons.  Dashed lines connect the scattering traces of the proteins/complexes 
with the calculated molecular weights as labeled. The colored lines under each 
peak represent the collected light scattering data as a distribution of molecular 
weights over the width of the chromatography peak. Numbers represent the 
calculated molecular weight from the scattering data. Concentrations of each 

















Table 1: Cargo Binding Competes with RcdA Dimerization.  
 
 
Table of molecular weights of the different RcdA-cargo complexes. The 
experimental column shows the complex mass measured by SEC-MALS. The 
stoichiometry column gives the stoichiometry of each protein consistent with the 
experimental mass. The predicted column lists the EXPASY predicted mass of 
each stoichiometry listed. Bolded text is the experimentally measured complex 




 Experimental (kDa) 
(±4 kDa) 
Stoichiometry Predicted (kDa) 
RcdA 36  RcdA2 (dimer) 37 
  RcdA (monomer) 19 
SpbR 42 SpbR (monomer) 43 
RcdA + SpbR 61 RcdA:SpbR 62 
TacA 124 TacA2 (dimer) 127 
RcdA + TacA 141 RcdA:TacA2 146 
PopA 41 PopA (monomer) 47 





Figure 2.3: RcdA Binds SpbR as a Monomer by AUC 
Sedimentation constants fitted from velocity ultracentrifugation of the 
RcdA- pbR complex. Each component was present at 25μM, either or 








Table 1). Strangely, despite having more mass than RcdA, we noticed that both 
PopA and SpbR elute after RcdA on our SEC columns, which we attribute to non-
specific interactions with the stationary phase of our column or that PopA and 
SpbR have different physical shapes than the RcdA dimer.  We confirmed the 
presence of both cargo and adaptor in these complexes by SDS-PAGE (Figure 
2.4).  
Our observation that RcdA binds it cargo as a monomer posed an interesting 
thermodynamic conundrum: if RcdA dissociation occurs with a slow off-rate or with 
a relatively tight binding constant, how does cargo binding outcompete RcdA 
dimerization? We answered this question by measuring the binding affinity of RcdA 
to cargo and to itself using several approaches. Using isothermal calorimetry, we 
determined that the dimerization constant of RcdA (KD = 7 µM, Figure 2.5) and 
dissociation constant between RcdA and SpbR (KD = 1 µM, Figure 2.5) were of 
similar order. Measurements with a labeled RcdA reporter using fluorescence 
polarization also revealed similar magnitudes for dimerization (KD = 2.5 µM) and 
SpbR binding (KD = 2.1 µM), (Figure 2.6). Finally, microscale thermophoresis 
measurements provides additional confirmation that RcdA binds itself and SpbR 
with similar ranges of affinity (RcdA-SpbR complex (average KD = 5 µM); 
dimerization (average KD = 3 µM)), (Figure 2.6).  
Taken together, these data suggest that RcdA binds cargo as a monomer and that 









Figure 2.4: SEC Coelution of RcdA-Cargo Complexes, related to Figure 2.2 
In this figure, we have replicated all of the complexes shown in Figure 2.2 and 
collected fractions for SDS-PAGE gel analysis. We used the chromatography 
setup used in the SEC-MALS experiments and collected fractions by 
disconnecting the light scattering detector which collects the waste and feed the 
output in hand fractionated tubes. We show the A280 signal from chromatograms 
of each complex and the gel profile of selected fractions for each chromatogram 
on the right. Fraction numbers are shown above the graph. Loaded fractions are 
numbered above each gel well, with the first lane showing the input sample 
before SEC analysis. Fractions were loaded with more volume (17uL) than the 
input samples (9uL) to account for dilution from the SEC column. The 
concentrations used were the same as the concentrations used in Figure 1 and 











Our data showing that RcdA dimers dissociate into monomers to bind all its cargo 
(Figure 2.3) was surprising and opened the door for further exploration of 
hypotheses regarding RcdA mechanism. One apparent hypothesis that came from 
this observation was that the monomeric form of RcdA is responsible for its 
stabilization when bound to cargo (Joshi et al., 2017). Our biophysical data 
showing monomeric RcdA binding cargo would explain the stabilization caused by 
the introduction of a nondegradable form of cargo (SpbRDD, TacADD or PopA), 








Figure 2.5: ITC analysis of RcdA Dimerization and SpbR Binding 
B) Representative ITC thermogram of the heat of RcdA dissociation, heats of 
injection shown on top. The sample syringe was loaded with 400μM RcdA and 
titrated into a cell containing buffer. Kdimerization values are the average of three 
independent replicates with error representing standard deviation. C) 
Representative ITC thermogram of the SpbR-RcdA complex formation, heats of 














Figure 2.6: Additional biophysical measurements of SpbR-RcdA binding 
and RcdA dimerization, related to Figure 2.5 
A) Microscale thermophoresis graph showing a titration of SpbR into labeled 
RcdA. A serial dilution of unlabeled  pbR starting at 30 μM was titrated into 200 
nM labeled RcdA. The average of three independent experiments and the 
standard deviation representing error are shown. B) Microscale thermophoresis 
graph showing a titration of RcdA into labeled RcdA. A serial dilution of unlabeled 
RcdA starting at  00 μM was titrated into 200 nM labeled RcdA. The average of 
three independent experiments and the standard deviation representing error are 
shown.  C) Additional replicates of Dimerization ITC. Experimental setup, buffers 
and concentration are the same as performed in Figure 1B. D) Additional 
replicates of RcdA-SpbR binding ITC. Experimental setup, buffers and 


















Figure 2.7: RcdA Cargo Competition Model 
Cartoon illustrating the competition between dimerization and cargo binding. All 









2.4 Heterodimerization of RcdA slows RcdA Autodegradation 
Our initial hypothesis that RcdA autodegradation suppression in the presence of 
cargo is due to monomerization of RcdA came with two implications: that one 
subunit of RcdA is insufficient for RcdA degradation and that one copy of the C-
terminal tail is also insufficient for degradation. We sought to devise a system 
where we could generate a heterodimer of RcdA that contains one subunit with a 
C-terminal tail and another subunit that lacks a C-terminal tail. Because the C-
terminal tail of RcdA is necessary for RcdA degradation (Joshi et al., 2017) we 
hypothesized that we could form a heterodimer of RcdA that consist of one 
subunit of WT RcdA and one subunit of RcdAΔC by mixing both species. If our 
hypothesis that both subunits of RcdA are needed for RcdA degradation, then 
our heterodimeric RcdA complex lacking one wildtype subunit should be 
protected from degradation. Consistent with this hypothesis, addition of excess 
RcdAΔC suppressed RcdA degradation in the presence of CpdR and ClpXP 
(Figure 2.8). While this data is consistent with a model where monomeric RcdA is 
protected from degradation, we sought to test this model by generating a 









Figure 2.8: RcdA Heterodimerization Protects RcdA from Degradation 
RcdA degradation at a final concentration of µM in vitro is inhibited in the 
presence of excess ( 0µM) RcdAΔC. A representative gel and quantifications of 
triplicates are shown below. A cartoon illustrating the heterodimer complex is 






2.5 Generation of a Monomeric Variant of RcdA 
To specifically test how a monomer of RcdA affects it function, we sought to 
generate a monomeric variant of RcdA. During our initial attempts to co-
crystallize RcdA with a TacA peptide to characterize RcdA:cargo interactions, we   
crystallized the apo form of RcdA in a different packing conformation than what 
was previously published in the original crystal structure (Crystallography 
completed by Madeleine Sutherland). Based on the published crystal structure of 
RcdA (Taylor et al., 2009, PDB: 3CTW) and our own in-house solved structure of 
RcdA, there were two distinct dimer interfaces that were annotated. In the 
published crystal structure, there were several amino acids that contain the 
highest percentage of buried surface area in the predicted dimer interface as 
predicted by the PDB PISA server for macromolecular interfaces. We identified 
leucine 82 (L82) as a residue that had the highest buried surface area 
percentage by the PDB PISA server as a candidate for mutation (Figure 2.9). In 
the second interface found in our in-house solved structure, we identified 
residues Arginine 131 and 135 (R131 and R135) as important residues in that 
interface (Figure 2.9). We mutated L82 to glutamic acid (L82E) and alanine 
(L82A) and R131 and R135 to glutamic acids (R131/5E) to disrupt each 
interface. We purified both proteins and ran them and performed SEC-MALS to 
confirm the molecular mass of each species. While the RcdA131/5E and L82A 
variants ran as a dimer species that coeluted with WT RcdA (Figures A.4-A.5), 




after WT RcdA and had a mass consistent with a monomeric species of RcdA 
(19kDa, Figure 2.10). We confirmed that RcdA L82E is incapable of forming a 
dimer by using fluorescence polarization as a readout of dimerization. While 
wildtype RcdA was capable of increasing polarization when added to a 
fluorescently labeled RcdA reporter, suggesting heterodimerization, RcdA L82E 
did not show the same trend (Figure 2.10). Finally, we tested our hypothesis that 
a monomeric form of RcdA is incapable of being degraded by testing whether 
RcdA L82E could be degraded in vitro and in vivo. Consistent with our model, 
RcdA L82E was stable in vitro throughout the time course of a degradation assay 
similarly to a cargo-stabilized WT RcdA (Figure 2.11). Similarly, RcdA L82E was 
not turned over in vivo in a translational shutoff assay when expressed from the 






Figure 2.9: Alternative RcdA Dimer Interfaces and Residues Important for 
Packing 
A) Annotated dimer interface from originally published RcdA crystal structure 
(Taylor et al., 2009, PDB 3ctw). Leucine 82 is highlighted as yellow 
spheres in both subunits for visualization. B) Annotated dimer interface 
from in-house solved RcdA structure (unpublished). Arginines 131 and 







Figure 2.10: The L82E Variant Forms a Monomer by SEC-MALS and 
Fluorescence Polarization 
A) The L82E variant forms a monomeric protein (grey trace) compared to WT 
RcdA (black trace) by SEC-MALS. A PymoL illustration of the L82 residue 
is shown on the left. B) Fluorescence polarization reporting on RcdA 
dimerization. 20μM unlabeled RcdA and RcdA L82E was added to each 





Figure 2.11: The L82E Variant is Incapable of Being Degraded 
A) In vitro gel-based degradation of 3 µM RcdA alone, 3 µM RcdA with 3 µM 
SpbRDD, or 3 µM RcdA L82E alone. Quantification of three independent replicates 
is shown on the right, error bars represent standard deviation..B) Chloramphenicol 
shutoff assays monitoring the degradation of RcdA and RcdA L82E in cells 
expressing wildtype RcdA or RcdA L82E. Quantification of the average of 3 




2.7 The L82E Variant is Defective in Some Cargo Binding and Delivery 
Our generation of a stable monomeric variant of RcdA allowed us to test directly 
whether the interface used for dimerization was the same interface used for cargo 
binding. We next tested the ability of RcdA L82E to bind and deliver different RcdA 
cargo. SpbR and TacA are substrates of ClpXP that require RcdA for efficient 
degradation, while PopA is an adaptor that binds RcdA to expand its substrate 
profile (Duerig et al., 2009, Ozaki et al., 2014).  We used wildtype RcdA or RcdA 
L82E labeled with fluorescein and fluorescence polarization as a proxy for cargo 
binding.  Using this assay, we found that wildtype RcdA bound all three cargo (n.b., 
DBDTacA is the minimal domain of TacA needed for RcdA degradation) (Figure 
2.12). The monomeric RcdA L82E was unable to form a complex with SpbR and 
DBDTacA, but surprisingly, bound PopA with affinity equivalent to wildtype RcdA 
(Figure 2.12). SEC-MALS and SDS-PAGE analysis of fractions confirmed these 
































Figure 2.12: The L82E Variant is Selectively Defective in Cargo Binding by 
Fluorescence Polarization 
A) Fluorescence polarization of labeled RcdA (black) or RcdA L82E (grey) in 
the presence of SpbR, DBDTacA and PopA. 100nM of each labeled reporter 
was incubated with 20μM cargo for 45 minutes and the polarization of 
labeled RcdA or RcdA L82E was measured, three independent replicates 
are shown with average and standard deviation. B) Fluorescence 
polarization curves of the PopA-RcdA or PopA-RcdA L82E complex. A 
serial dilution of unlabeled PopA starting at 40μM was titrated into 200nM 
































Figure 2.13: The L82E Variant is Selectively Defective in Cargo Binding by 
SEC-MALS and Analytical SEC 
A) Representative SEC-MALS chromatograms of RcdA L82E in the presence of 
SpbR or PopA. Wildtype RcdA incubated with SpbR, PopA alone, and RcdA 
L82E alone are shown for comparison. The colored lines under each peak 
represent the collected light scattering data as a distribution of molecular weights 
over the width of the chromatography peak. Numbers represent the calculated 
molecular weight from the scattering data. B) Chromatograms and SDS-PAGE 
gels of collected fractions of complexes shown in Figure 2.13. Fraction numbers 
are shown above the graph and each gel. Loaded fractions are numbered above 
each gel well, with the first lane showing the input sample before SEC analysis. 











Consistent with the defects in SpbR and TacA binding, the RcdA L82E variant 
showed less stimulation of the CpdR-ClpXP mediated degradation of these 
substrates in vitro (Figure 2.14).  This deficiency was not due to a failure of RcdA 
L82E to bind the CpdR-ClpX complex, as fluorescence polarization assays that 
monitor ClpX:CpdR:RcdA ternary complex formation (Joshi et al., 2015) showed 
that both RcdA variants were able to bind the ClpX:CpdR complex with similar 
affinity (Figure 2.15) 
PopA binds RcdA directly, and in a c-di-GMP dependent manner promotes 
degradation of CtrA (Smith et al., 2014, Ozaki et al., 2014). To test the effects on 
PopA-mediated substrate delivery, we used a GFP reporter fused to the minimal 
domains of CtrA needed for regulated degradation (GFP-CtrARD+15), (Smith et 
al., 2014). Unlike the case for TacA or SpbR, the RcdA L82E variant was capable 
of stimulating PopA-mediated CtrA degradation (Figure 2.14). These data show 
that disrupting the dimer interface of RcdA reduces binding to some substrates, 
but this monomeric variant can still bind to an activated ClpXP and deliver 
permissive substrates (such as CtrA). Consistent with an overlap in interfaces for 
cargo and dimerization, locking RcdA into a dimer by crosslinking also prevents 
cargo binding, while L82E treated with the same concentrations of glutaraldehyde 
did not affect the L82E variant’s ability to bind PopA (Figure 2.16) Taken together 
with the observation that all cargoes can compete with RcdA dimerization, our 












Figure 2.14: The L82E Variant is Selectively Defective in Cargo Delivery  
A) In vitro gel-based degradation assay of SpbR or in the presence of RcdA 
or RcdA L82E. Full gels are shown in SI Appendix Fig. S3.  Quantification 
of three independent replicates showing means and error bars (standard 
deviation). B) In vitro fluorescence degradation assay of GFP-CtrARD+15 
in the presence of RcdA or RcdA L82E. Each fluorescence trace is the 
average of three independent replicates with error bars showing standard 
deviation. C) GFP-DBDTacA reporter degradation curves with RcdA and 
RcdA L82E. Fits are to a modified hyperbolic equation as outlined in the 
methods. D) GFP-CtrA reporter degradation curves with RcdA and RcdA 


























Figure 2.15: The L82E Variant Interacts with the ClpX:CpdR Complex with 
Same Affinity as WT RcdA  
A) Illustration of polarization assay for measuring binding to CpdR-ClpX.  A 
fluorescently labeled RcdA variant increases fluorescence polarization 
signal when bound to the CpdR-ClpX complex because of decreased 
rotation. B) Fluorescence polarization of 200 nM RcdA and RcdA L82E 
increase only with CpdR, ClpX, and ATPgS present. C) Competition of 
fluorescently labeled RcdA L82E from the CpdR-ClpX complex by 
unlabeled wildtype or L82E RcdA variants show they bind to the CpdR-
ClpX complex equally well (IC50 = 5 µM). The fluorescent monomeric 
RcdA L82E was used to prevent formation of dimers of unlabeled and 





























Figure 2.16: A crosslinked RcdA Dimer Cannot Interact with PopA  
A) Coomassie stained SDS-PAGE gels of crosslinked 100μM RcdA and L82E 
after incubation with increasing concentrations of glutaraldehyde, demonstrating 
formation of a dimeric species. The asterik on the L82E crosslinking gel indicates 
a higher molecular weight band that did not travel through the gel matrix. B) (left) 
Illustration of assay to determine binding of RcdA to PopA using a fluorescently 
labeled RcdA L82E. PopA binding to fluorescently labeled RcdA L82E results in 
high polarization of the RcdA L82E reporter.  Native RcdA will bind PopA 
resulting in free labeled RcdA L82E which has a low polarization signal.  (right) 
Polarization signal from labeled RcdA L82E in the presence of the indicated 
components. Note that wildtype RcdA causes a decrease in polarization, while 














2.8 The dimer interface is protected from exchange in the presence of 
cargo 
To determine how different cargoes interact with RcdA, we used hydrogen 
deuterium exchange-mass spectrometry (HDX-MS) which measures differences 
in deuterium uptake in the peptide backbone to determine protein-protein 
interaction surfaces (24-25). We first compared high and low concentrations of 
RcdA to map the dimer interface (Figure 2.18) and found these data to be 
consistent with the comparison between monomeric RcdA L82E and the dimeric 
wildtype RcdA that also highlights the dimerization interface (Figure 2.17A). We 
then measured deuterium uptake of RcdA incubated with excess DBDTacA or PopA 
to define potential interaction surfaces with these cargoes (Figure 2.17A). Each 
condition is summarized in a differential deuterium uptake plot as a heat map 
showing percent deuterium uptake for each peptide and regions of largest 
protection (>15%) mapped onto a surface rendition of a RcdA monomer (Figure 
2.17A). Individual deuterium uptake plots for selected regions of largest protection 
are provided in Figure 2.17B and Figure 2.19.   
Based on the PDBePISA server and the 3CTW crystal structure of RcdA, the most 
buried residues in the dimer interface lie between residues 34-45 and 71-101. We 




and 80-97 as being most protected in the wildtype dimer (Figure 2.17A). This result 
further confirms how the L82E mutation disrupts the dimer interface to generate a 
monomeric variant. Consistent with our biochemical results in Figure 3, DBDTacA 
also binds the region of the dimer interface containing the L82 residue with most 
protection at residues 79-101 supporting our observation that RcdA L82E fails to 
deliver TacA for degradation. Interestingly, PopA also binds the dimer interface, 
but principally protects residues 26-70, with the L82 containing region of RcdA 
showing no substantial protection. We conclude that consistent with our 
biochemical data, TacA and PopA both bind the RcdA homodimer interface to 

















Figure 2.17: The Dimerization Interface is Protected in the Presence of 
Cargo 
A) Differential uptake heatmap plots of  5μM RcdA compared with  5μM RcdA 
L82E (dimerization), 600nM RcdA incubated with 20μM DBDTacA (TacA), or 
600nM RcdA incubated with 20μM PopA (PopA). Regions of 15% or greater 
protection are highlighted in blue on a surface rendition of the RcdA 
monomer structure (PDB ID: 3CTW). B) Deuterium uptake plots of selected 
peptides. Data is plotted as the mean of three replicates with the standard 
deviation plotted as error bars. See chapter 2 appendix for more peptides 



























Figure 2.18: Mapping of The Solution Dimer Interface 
Differential uptake heatmap plot of 20μM versus 600nM RcdA to illustration 
dimerization interface. Given KD determined in Figure 2.5, 20 uM would be 



















Figure 2.19: Additional Protected HDX Peptides, Related to Figure 2.17 
Individual deuterium uptake plots for regions displaying >15% protection in the 
RcdA-L82E, RcdA-DBDTacA, and RcdA-PopA HDX datasets. Quantification of 
three independent experimental replicates is shown with the mean and standard 
deviation plotted as error bars. 
 
 
2.9 Mutations in the PopA interaction region highlight differences in cargo 
binding  
Our HDX-MS data highlights two regions in RcdA as protected upon PopA binding, 
one of which includes a cluster of highly conserved basic residues (R49, K53, R57) 
(Figure 2.20). We had previously identified these residues by modeling a peptide 
of TacA onto the RcdA crystal structure (Appendix A.9). We mutated these 
residues to glutamic acid to generate a variant that we refer to as RcdA 3E for 
brevity (Plasmid made by Madeleine Sutherland), (Figure 2.21). Based on our 
biochemical studies (Figure 3) we predict that both TacA and SpbR bind similar 
regions of RcdA, including L82, that are distinct from the regions preferred by PopA 
(Figure 4).  Consistent with this hypothesis, while the RcdA 3E fails to bind PopA 
based on SEC-MALS, it forms a complex and coelutes with SpbR with a measured 
mass consistent with the native complex and a dimer of mass consistent with 
wildtype RcdA (Figure 2.22).  Given the failure to bind PopA, we were not surprised 




Consistent with the preserved binding to SpbR and TacA, RcdA 3E was active for 
their degradation, although not to fully wildtype activity (Figure 2.23), which we 
suggest may be due to folding defects of the purified protein. Overall, these data 
suggest that while the homodimer interface of RcdA is generally responsible for 


























Figure 2.20: RcdA Sequence Alignment Reveals Conserved Residues  
Sequence alignment of RcdA in other alpha-proteobacteria (WebLogo, Berkeley). 
The upper panel highlights in red the residues (R49, K53, R57) mutated to 
glutamic acid to general RcdA 3E. The lower panel highlights in red the L82 









Figure 2.21: Illustration of the RcdA 3E Mutant  
Illustration of region of RcdA protected upon PopA incubation (in blue). In orange 
are the 3 residues (R49, K53, R57) mutated to glutamic acids in RcdA 3E. These 
mutations were not involved in interactions in the dimer interface and we 















Figure 2.22: The RcdA 3E Mutant is Selective for Cargo Binding  
A) Representative SEC-MALS traces for the PopA or SpbR mixtures with 
RcdA 3E (red). The complex of native RcdA and cargo (black) and the 
cargo alone (blue) is shown for comparison. The colored regions under 
each peak represent the collected light scattering data as a distribution of 
molecular weights over the width of the chromatography peak. Numbers 
represent the calculated molecular weight from the scattering data. B) 
SEC-MALS traces of RcdA 3E. 25μM RcdA 3E was injected over the 
column. C) Chromatograms of all the SEC-MALS data collected in Figure 
2.21A. Hand fractionation windows are shown above the graph. The 
concentrations used were the same as the concentrations used in Figure 
2.22A. D) SDS-PAGE gels of collected fractions of complexes shown in 
Figure 3. Loaded fractions are numbered above each gel well, with the 











Figure 2.23: The RcdA 3E Variant is Selective for Cargo Delivery 
A) In vitro fluorescence degradation assay of GFP-CtrARD+15 in the 
presence of RcdA or RcdA 3E. Fluorescence traces are the average of 
three independent replicates with error bars showing standard deviation. 
The +RcdA control is the same control that was used in Figure 3C and is 
shown here for comparison to RcdA 3E. B) In vitro gel-based degradation 
assay of SpbR or TacA in the presence of RcdA or RcdA 3E. 








2.10 Defects in cargo binding affect target degradation in vivo  
We finally investigated the in vivo consequences of altering RcdA-cargo 
interactions. Previous in vivo work had shown that altering parts of the RcdA 
interface did not dramatically affect CtrA delivery during the cell cycle (Taylor et 
al., 2009). However, our specific mutations had not been tested for defects in vivo. 
During the cell cycle of Caulobacter crescentus, the transition from G1 to S phase 
is accompanied by a morphological change from a motile swarmer cell to a sessile 
stalked cell facilitated by degradation of RcdA-dependent substrates. Because of 
this transition, defects in cell-cycle are often accompanied by changes in 
morphological features. We generated strains that express RcdA, RcdA L82E or 
RcdA 3E at the xylX locus in ΔrcdA strains, which allows for titration of RcdA using 
the inducer xylose. ΔrcdA strains have longer stalks and reduced growth in low 
percentage agar, indicative of defects in cell-cycle stages and development as 
stalk growth (McGrath et al., 2006, Joshi et al., 2015). At low levels of inducer, 
RcdA variant levels driven by the xylX promoter were similar to that of the wildtype 
control (Figure 2.24), and in these conditions, stalk length was compromised in 
both RcdA L82E and 3E backgrounds (Figure 2.24), while growth in low 
percentage agar was more affected in the RcdA 3E mutant (Figure 2.25). 
Curiously, under high induction, where RcdA levels are well above normal, stalk 
length was reduced to less than wildtype for all the alleles tested (included wildtype 




These data suggest that the different substrates stabilized by the different RcdA 
variants may drive defects in stalk length and agar growth separately. Consistent 
with this and our in vitro results, in vivo degradation assays showed that strains 
expressing RcdA L82E are deficient in SpbR degradation (Figure 2.26), while 
strains expressing RcdA 3E failed to degrade CtrA during either asynchronous 









Figure 2.24: Expression of the L82E and 3E Variants causes Stalk 
Formation Defects  
A) Western blot of steady state levels of integration strains expressing RcdA, 
L82E or 3E from the xylose locus at low induction (0.002% xylose). 
Quantifications are normalized to wildtype levels. B) Stalk length 
quantification and images of cells expressing RcdA, RcdA L82E or RcdA 3E 
from the xylose locus. Cells grown to exponential phase in media containing 
0.2% (hi: high inducer), 0.002% xylose (lo: low inducer) or 0.2% glucose 
(repressed). A one-tailed, unpaired t-test with α=0.05 was used to compare 





















Figure 2.25: The RcdA 3E Variant has Motility Defects  
A) Motility agar assay of each integration strain in PYE + low inducer (lo) or 
glucose repressor (-) agar plates with wildtype RcdA, RcdA(L82E) or 
RcdA(3E) in each spot. Images have the same absolute perimeter size. B) 
Quantifications of 3 biological replicates of the motility assays in low 
induction (+xylose) and no induction (+glucose) showing that cells 











Figure 2.26: The RcdA L82E and 3E Variants are Selective for Cargo 
Delivery In Vivo 
A) Chloramphenicol shutoff assays monitoring the degradation of SpbR and CtrA 
in cells expressing wildtype RcdA or RcdA L82E. B) Synchronized cell growth of 
each integration strain expressing wildtype RcdA, RcdA L82E or RcdA 3E, 
showing that CtrA oscillations are lost in cells expressing RcdA 3E. Cell samples 







2.11 Dimerization limits overly prolific RcdA activity 
When we monitored cell-cycle progression, we noticed that CtrA levels were 
slightly lower with RcdA L82E upon minimal induction of this mutant (Figure 2.26). 
Interestingly, in our biochemical studies we noticed that at lower RcdA 
concentrations (300 nM) the rate of PopA-mediated CtrA degradation in the 
presence of RcdA L82E was faster than that found with wildtype RcdA (Figure 
2.27).  When we generated enzyme-substrate reaction curves under these 
conditions and fit to Michelis-Menten kinetics, we found that RcdA L82E was 2-fold 
more active for PopA mediated CtrA degradation at limiting concentrations of 
protease and adaptor (Figure 2.27).  Since the RcdA dimer interface is also used 
to bind cargo (such as PopA), this observation is most consistent with a model 
where dimerization normally limits the specific activity of RcdA for cargo delivery. 
We further explored this dimerization driven limit on RcdA activity in normal 
physiology by constructing merodiploid strains that expressed either wildtype 
RcdA or RcdA L82E from the native rcdA promoter. We found that steady state 
levels of CtrA are lower and degraded faster in the RcdA L82E strain than in the 
wildtype strain (Figure 2.28). During synchronized growth, CtrA is lost more rapidly 
during the G1 to S transition, and re-accumulation of CtrA in predivisional cells is 
reduced (Figure 6F; SI Appendix Fig. S8G).  Finally, to determine the overall 
fitness cost of this mutation, we used a competition assay and found that strains 
expressing only RcdA L82E are at a fitness disadvantage compared to wildtype 




dimerization limits RcdA activity and bypassing this restriction results in persistent 
degradation of substrates such as CtrA.  
 
 
Figure 2.27: The RcdA L82E Facilitates Faster Degradation of CtrA at Lower 
Concentrations of RcdA 
A) Normalized fluorescence degradation curves of GFP-CtrA in the presence of 
different concentrations of RcdA and RcdA L82E. 500nM PopA,  μM cyclic di-
GMP, 300nM RcdA or L82E, 0. μM ClpX, and 0.2μM ClpP and  μMof GFP-CtrA 
was used in this experiment. B) Initial rates of GFP-CtrA degradation as a 
function of adaptor. 500nM PopA,  μM CdG, 300nM RcdA or L82E, 0. μM ClpX, 
and 0.2μM ClpP and varying concentrations of GFP-CtrA reporter were used in 




















Figure 2.28: The RcdA L82E Variant Reduces Cell Fitness and Delivers CtrA 
Faster In Vivo 
A) Normalized CtrA steady levels in asynchronous cultures and their degradation 
during shutoff. Quantifications are the averages of three biological replicates. B) 
Representative westerns of shutoff experiments for merodiploid strains 
expressing RcdA or RcdA L82E as the sole copy of RcdA under the control of the 
PrcdA promoter. C) Quantification of replicate shutoff experiments. D) Fitness 
competition assay between wildtype and PrcdA::RcdA or PrcdA::RcdA L82E.  For all 
data except the asynchronous shutoff, which were duplicate experiments, 
average and standard deviation of three independent replicates is shown. E) 
Representative westerns of synchronized cell growth of merodiploid strains 
expressing either RcdA or RcdA L82E as the sole copy of rcdA under the control 
of the PrcdA promoter. Quantification of replicate experiments are shown in Figure 












Adaptor mediated degradation is critical for bacteria. Our results demonstrate a 
surprising feature of the cell cycle adaptor system in Caulobacter, where binding 
of a cargo to the RcdA adaptor competes with homodimerization. This competition 
results in stabilization of RcdA, protecting it from self-degradation by ClpXP, while 
providing a relatively broad binding surface for cargo binding. We note that the 
cellular concentration of RcdA estimated by ribosome profiling is 6 µM and SpbR, 
PopA and TacA are between 2-4 µM each (Aretakis et al., 2019). This implies that 
total cargo concentration is likely in excess of RcdA, driving the RcdA equilibrium 
towards the monomer form and protecting RcdA from degradation until target 
substrates are delivered by RcdA. Our binding data is consistent with the model 
that different classes of cargo can interact with specific regions of this surface, with 
our direct measurement by HDX-MS and our mutation data showing that we can 
selectively influence particular substrate binding and degradation (Figure 2.29). 
Interestingly, CpdR and RcdA are conserved throughout α-proteobacteria, while 
PopA is only present in Caulobacter and closely related bacteria (Brilli et al., 2010, 
Ozaki et al., 2014). The region mutated in our RcdA 3E variant may represent the 
binding interface for currently unknown adaptors that fulfill the role for PopA in 
other species where CtrA is degraded such as Sinorhizobium meliloti, (Pini et al., 
2015). Recent structures show that the E3 ubiquitin ligase adaptor Skp1 buries its 









Figure 2.29: Model of RcdA binding and delivery mechanism 
Highlighted structure illustrating the different interactions sites of RcdA. In gold is 
the dimer interface. In purple is the site involved in the SpbR and TacA interaction, 
which includes the L82 residue. In ruby is the site involved in the PopA interaction, 
which includes residues R49, K53, R57. Cartoon model of how the oligomerization 
state of RcdA affects its activity and self-degradation. When not bound to cargo, 
RcdA is dimeric and delivered to a CpdR-bound ClpXP for degradation. Cargo 
binding at different interaction sites by different cargo (SpbR/TacA or PopA) 














Because protease adaptors catalyze the irreversible destruction of targets, we also 
considered how dimerization of RcdA could regulate adaptor activity. Our results 
support two mechanisms for the role of dimerization in restricting adaptor activity:  
First, because the RcdA homodimer is degraded robustly, overlapping the dimer 
interface and cargo binding site adjusts RcdA levels tuned to substrate availability. 
Our results show that RcdA monomers are not degraded and that binding to cargo 
results in loss of RcdA dimerization. Once the substrates are degraded, RcdA 
homodimers would form more readily and be destroyed. Similarly, RcdA would 
never be fully eliminated as once levels drop below the dimerization constant, the 
shift to the monomeric species would stabilize the adaptor.  
Second, masking substrate interaction surfaces by dimerization appears to limit 
degradation of substrates directly as seen with accelerated PopA-mediated CtrA 
proteolysis in the presence of the monomeric RcdA variant (Figure 2.28).  
Essentially, the partner monomer of a homodimer acts as an inhibitor of cargo 
binding resulting in reduced degradation of substrates.  Our data show that there 
are physiological consequences to the loss of this limitation as cells expressing 
only monomeric RcdA have lower levels and faster degradation of the essential 
transcription factor CtrA, resulting in reduced fitness.  We note that other protease 
systems show similar constraints, for example, the N-domain of the Lon protease 




Not all dimeric adaptors share this competitive mechanism. For example, the 
SspB adaptor delivers proteins marked by the ssrA-tagging system to the ClpXP 
protease (Levchenko et al., 2000, Gottesman et al., 1998, McGinness et al., 
2007). Unlike RcdA, SspB binds substrates at sites far away from the dimer 
interface (Chien at al., 2007) and SspB delivery is optimal when two molecules of 
substrates are bound per SspB dimer (McGinness et al., 2007, Bolon et al., 
2004). Therefore, SspB activity would not be limited by competition from dimer 
formation.  We reason that because ssrA-tagged proteins naturally arise from 
failed translation (Levchenko et al., 2003, Keiler et al., 2015), these targets 
should always be destroyed, therefore prolific SspB activity would not be toxic. 
By contrast, degradation of RcdA dependent substrates occurs only at a specific 
stage of the cell-cycle (McGrath et al., 2006, Joshi et al., 2015) and additional 
controls to limit this adaptor activity, such as the mechanism we describe here, 
would be beneficial.  We speculate that other adaptors that deliver substrates in 










2.13 Materials and Experimental Procedures 
Protein Expression and Purification. BL21(DE3) pLYS or X90 cells with 
expression plasmids for different proteins were grown at 37°C to an OD600 of 0.4-
0.6, then induced with 0.4mM IPTG for 3-4 h. Induced cells were then centrifuged 
at 7,000g for 10 minutes and resuspended in buffer containing 50mM Tris pH 8.0, 
300mM NaCl,  0mM imidazole,  0% glycerol, 5mM β-mercaptoethanol and 
100mM PMSF and frozen at -80°C until further use. Cells were lysed using a 
Microfluidizer system (Microfluidics, Newton, MA). The clarified lysate was bound 
over a Ni-NTA column for affinity purification. H6SUMO-tagged proteins were 
cleaved by Ulp1-his protease (36). Proteins were then purified using size exclusion 
and anion-exchange chromatography using Sephacryl 200 16/60 and MonoQ 5/50 
columns. ClpX and ClpP were purified as outlined in (9). Detailed purification 
protocols are available upon request. For all in vitro experiments RcdA 
concentrations are stated in terms of monomeric equivalents unless otherwise 
noted. 
Cloning and Molecular Biology. RcdA variants were cloned using around-the-
horn site-directed mutagenesis by amplifying the desired plasmid using 
pET23SUMO-RcdA as a template. To generate the ΔrcdAXylX::Pxyl integration 
strains, the pXGFPN-1 plasmid (37) was used a template to generate a vector with 
the RcdA, RcdA(L82E) and RcdA(3E) coding sequences under the xylose 
promoter. The coding sequence of RcdA, RcdA(L82E) or RcdA(3E) was amplified 




using Gibson assembly method (38). Competent ΔrcdA Caulobacter cells were 
transformed with pXGFPN-1-RcdA, RcdA(L82E) or RcdA(3E) containing plasmids 
and selected on 30 μg/mL spectinomycin/streptomycin plates. To generate RcdA 
or RcdA L82E merodiploid strains, we performed around the horn mutagenesis on 
the wildtype RcdA pENTR gateway cloning vector (EPC 721) using the same 
primers used to make the original L82E mutation. We transformed this plasmid into 
competent wildtype cells and selected on 50 µg/ml kanamycin containing PYE 
plates. We confirmed insertion of the L82E coding sequence by Sanger 
sequencing. 
In Vivo Protein Stability and Synchrony Assays. Wildtype or Caulobacter cells 
expressing different constructs from a xylose inducible promoter or from the native 
rcdA locus were grown in PYE media with appropriate antibiotic and xylose when 
required as outlined in the figure legends. Cells were grown to an OD600 of ~0.4 
with addition of 0.2-0.002% xylose or 0.2% glucose (when noted). Protein 
synthesis was blocked by addition of 30 μg/mL chloramphenicol and aliquots were 
taken at the timepoints indicated in the figures. For synchrony experiments, an 
asynchronous population of cells was grown to an OD600 of ~0.4 in PYE. Swarmer 
cells were harvested and isolated using Percoll density gradient centrifugation, 
then released into fresh PYE media containing 0.002% xylose (when needed) for 
progression through the cell cycle.  
Microscopy. Phase contrast microscopy was performed on glass slides layered 




with  00X ( x25 oil  ∞/0. 7) objective and 60 N-C  ″  00x camera was used. 
Images were analyzed with BacStalk (Drescher Lab, Max Planck Institute) 
software. Stalk distributions were compared using a one-tailed unpaired t-test with 
α = 0.05 (GraphPad Prism).  
Motility Assays. Motility assays were performed as described previously (36). 
Briefly, 0.3% agar plates containing varying concentrations of xylose and glucose 
were inoculated with three independent colonies of each strain for 3 days at 30°C. 
Colony sizes were determined using ImageJ (NIH). Quantifications were 
completed using ImageJ and plotted in GraphPad Prism. 
In Vivo Growth Competition Assay. Overnight cultures of a strain constitutively 
expressing the fluorescent reporter Venus (CPC798) were mixed with Wildtype, 
PrcdA::RcdA, PrcdA::RcdA L82E at a 1:1 ratio. Mixed strains were then diluted 
1:15000 into fresh media and allowed to outgrow for 24 hours. The initial 1:1 
mixture of cells was verified by phase contrast and fluorescence microscopy. 
Quantification of >100 cells was performed for 3 biological replicates. All final ratios 
were normalized to their starting ratios prior to dilution. Statistical analysis was 
performed using an unpaired t-test in GraphPad Prism.  
Western Blot Analysis. Aliquots withdrawn at indicated time points were spun 
down, resuspended in 2X SDS sample buffer, boiled at 95 °C for 10 min and then 
centrifuged. After centrifugation, 10 µl of clarified supernatant was loaded onto 




at 20V for 1 hour and probed for monoclonal rabbit anti-RcdA (1:5000), monoclonal 
rabbit anti-ClpP (1:5000), polyclonal rabbit anti-SpbR (1:5000), rabbit anti-FtsZ 
(1:5000), or rabbit anti-CtrA (1:5000). Following overnight primary probing at 4°C, 
the membranes were washed 3 times with TBST. Proteins were then visualized 
using IRdye-labeled goat anti-rabbit antibody (LI-COR Biosciences) at 1:10000 
dilution and an Odyssey Scanning system (LI-COR) 
Fluorescence Polarization and Maleimide Labeling. Purified RcdA or RcdA 
mutants were labeled with Fluorescin-5-Maleimide (Thermo ScientificTM). Purified 
protein at ~8-10 mg/mL was buffer exchanged into labeling buffer (50 mM Tris pH 
7.0, 150mM NaCL, 2mM TCEP). Fluorescin-5-Maleimide was dissolved in DSMO 
and added to protein at a 20-fold molar excess to cysteine. Labeling reactions were 
completed at 4°C overnight. Free dye was removed using a PD-MidiTrap column 
(GE Healthcare) and Amicon Ultra-15 Centrifugal Filter Units in a buffer containing 
20mM HEPES pH 8.5, 100mM KCL, 10mM MgCl2 and 0.05% Tween. 
Confirmation of protein labeling was verified using a Typhoon imaging system (GE 
Healthcare). The labeled protein was aliquoted, and flash frozen at -80°C.  
Fluorescence polarization binding experiments were performed with 100 nM 
labeled Rcda or RcdA L82E and varying concentrations of cargo. The binding 
reaction was incubated at 25°C for 1hr to reach equilibrium. Polarization 
measurements were read from 40uL of these mixtures using opaque black 384-
well plates using a SpectraMax M5 plate reader (Molecular Devices) with excitation 




constants were calculated by fitting the polarization data using GraphPad Prism to 
a one site, total and nonspecific binding equation P = Pmax*[X]/([X] + Kd) + NS*[X] 
+ Background, where Pmax is the maximum specific binding value, P is the 
polarization value, NS is the slope of linear nonspecific binding constrained to be 
greater than 0, and the background is the polarization value when [X] is 0. Error 
bars are calculated from the standard deviation between replicates of experiments. 
All RcdA concentrations are in terms of monomeric equivalents unless otherwise 
noted. 
Chemical Crosslinking. For crosslinking experiments, 100 μM RcdA or L82E was 
incubated with increasing concentrations of glutaraldehyde as annotated. 
Crosslinking was performed in 20 mM HEPES buffer, pH 7.5 with 100mM KCL and 
quenched after 2 hours of incubation at room temperature with 1M Tris pH 8. The 
resulting mix was then desalted into the same HEPES buffer used for 
Fluorescence Polarization experiments. 
Isothermal Titration Calorimetry (ITC). ITC experiments were completed using 
a Malvern-autoiTC200 automated system (Malvern). Measurements were taken at 
25°C. The reference cell was filled with 20 mM HEPES pH 8.5, 100mM KCL and 
10% glycerol. This buffer was used for all ITC experiments and for dialysis of each 
protein into the same buffer prior to the experiment. The sample cell was loaded 
with 400μL of 40μM pbR and the stirring syringe was loaded with  20μL of 400μM 
RcdA. 19 injections of RcdA into SpbR were used to build the binding isotherm. 




identical sites equation Kd = (Θ)/(( -Θ)*[X]), where Θ is the fraction of sites 
occupied by ligand X and [X] is the concentration of ligand X. For dimer 
dissociation, the sample cell was loaded with 400μL of the buffer described above  
and the stirring syringe was loaded with  20μL of 400μM RcdA. Dissociation data 
was fit to the dimer dissociation model in ORIGIN (P2 -> 2P)  
Size-Exclusion Chromatography with Multi-Angle Light Scattering. Each 
protein complex was allowed to bind at room temperature for 45 minutes. The 
complexes were then injected onto a T Kgel™ G3000  EC column equilibrated 
in 20mM HEPES buffer, pH 7.0 with 100mM Potassium Chloride and 10% glycerol 
(Tosoh Biosciences) at room temperature. The SEC column was coupled to an 18-
angle light scattering detector (DAWN HELEOS-II) and a refractive index detector 
(Optilab T-rEX) (Wyatt Technology). Data was collected every second and the flow 
rate was set to 0.5 mL/min. Data analysis was carried out using the program 
ASTRA (Wyatt Technology). Monomeric bovine serum albumin (BSA; Sigma) was 
used for calibration of the light scattering detectors and general data quality 
control. Measurements were taken at 25°C. The light scattering data was collected 
across a window containing the entire chromatographic peak for a full distribution 
of molecular weights, shown underneath each chromatogram. The monomeric 
equivalent concentrations used in the SEC-MALS experiments are as follows 
unless otherwise noted in the figure legends: 25μM RcdA, 25μM RcdA L82E, 25μM 




SpbR for Figure 1 and Figure 3. The concentrations we used in our coelutions 
studies were the same concentrations used in our SEC-MALS studies.  
Microscale Thermophoresis (MST). The MST experiments were performed 
using a Monolith NT.115 instrument (NanoTemper). Fluorescin-5-Maleimide 
labeled RcdA was incubated with increasing concentrations of unlabeled RcdA in 
the same buffer used in the polarization experiments. The measurements were 
performed at 20% MST power with 40% LED Power and with 3 s laser on time and 
25 s off time. The Kd values were calculated using MO Affinity Analysis software 
(NanoTemper) and fit to the nonlinear equation Fnorm = [unbound + (bound-
unbound) / 2 * (FluoConc + c + Kd – Sqrt((FluoConc + c + Kd)^2 – 4*FluoConc*c)], 
where unbound and bound are the thermophoresis values of the unbound and 
bound states, FluoConc is the fixed concentration of the fluorophore, Fnorm is the 
normalized fluorescence, and c is the concentration of the unlabeled protein. 
Hydrogen-Deuterium Exchange Mass Spectrometry. Hydrogen-deuterium 
exchange was measured on a Synapt G2Si high definition mass spectrometer 
(Waters). Deuterium exchange and quenching steps were performed using an 
automated HDX robotics platform (Waters). Samples were diluted 1:16 in D2O-
containing buffer containing 0.1 mM K2HPO4 to final concentrations as specified in 
the figure legends. Deuterium exchange was allowed to take place for 0, 1, 10 and 
60 minutes at 25°C, with staggered starts for each dilution reaction. After all 
reactions were completed, aliquots were removed and diluted 1:2 into cold quench 




subsequentially run over an immobilized Water ENZYMATE immobilized pepsin 
column (ID: 2.1 length: 30mm) at a flow rate of 0.15mL/min at high pressure 
(~11000 psi) for peptide digestion. Prior to HDX analysis, the quality of each 
sample was assessed using SDS-PAGE and size-exclusion chromatography.  
Three independently prepared experimental replicates and labeling reactions were 
performed for each condition and averaged in the peptide uptake plots. Blank runs 
were run in between each analysis to avoid peptide carry-over. Continuous lock-
mass correction was performed using leu-enkephalin compound. Timepoints and 
analysis were randomized to ensure no biasing of results and to ensure variation. 
Peptides were ionized and separated by electrospray ionization for analysis in 
MSE mode at a mass resolution of 50-2000 m/z range. Identification of peptides 
and analysis of the uptake plots and charge states for each peptide were 
completed in Protein Lynx Global Server (PLGS) and the software DynamX 
(Waters). Differential uptake heatmaps and uptake plots were plotted and created 
in Adobe Illustrator and in GraphPad Prism. Protections of greater than 15% are 
shown on the surface renditions of the RcdA structure (PDB 3CTW) using PyMol 
(Schrodinger Software) 
In vitro Degradation Assays. Degradation of proteins was monitored using SDS-
PAGE gels as described previously (21). The concentrations of different proteins 
used in degradation reactions are indicated in the figure legends. Degradation of 
GFP-CtrARD+15 was monitored with the loss of fluorescence over time as 




were as follows unless otherwise noted: 3μM RcdA, 3μM RcdA(L82E), 3μM 
RcdA(3E), 2μM CpdR, 0.2μM ClpX6, 0.4μM ClpP14,  μM GFP-DBDTacA, 4μM 
 pbR, 4μM TacA, 2μM GFP-CtrARD+15, 5mM ATP. For GFP-CtrARD+15 
experiments in Figure 6C, we used 1uM GFP-CtrARD+ 5, 500nM PopA,  μM 
CdG, 300nM RcdA or L82E, 0. μM ClpX, and 0.2μM ClpP. GFP-CtrARD+15 and 
GFP-DBDTacA curves were fit to a modified hyperbolic equation with the form of:  Y 
= ((Vmax * [RcdA]) / (Kact + [RcdA])) + A, where A is a baseline constant, or to the 
Michaelis-Menten equation using GraphPad Prism. 
Sedimentation Velocity Analytical Ultracentrifugation. Sedimentation Velocity 
experiments were completed using a Beckman ProteomeLab XL-1 Analytical 
Ultracentrifuge (Beckman). Samples were diluted into 20 mM HEPES pH 8.5, 
100mM KCl, 10% glycerol at the concentrations indicated in the figure legends. 
The samples were spun at 55,000 g overnight at 25°C. The ρ and v values used 
for data fitting were determined using SEDNTERP and the amino acid sequence 
for each protein. The sedimentation velocity data was directly fit to the c(s) 
distribution method using the program SEDFIT and using the first 100 velocity 
scans for each condition. The resulting distributions from each experiment were 
then plotted in GraphPad Prism. The final concentrations used were the same 






Bacterial Strains Used in This Study: 
Organism Name Description Source 






















 X90 T7 recombinant 
protein expression 
From Bob Sauer 
 EPC100 dh5alpha pQE70-
his-ClpP  
(Chien et al., 
2007) 




 EPC162 BL21DE3 375 
eGFP-His6-
CtrARD+15 
(Smith et al., 
2014) 
 BPC180 Top10 pXMCS-2 This study 
 BPC238 BL21DE3 plysS 
pET23 ClpX  
(Chien et al., 
2007) 
 EPC196 BL21DE3 plysS 
pET23b 
His6Sumo-CpdR 
(Lau et al., 2015) 
 EPC677 BL21DE3 plysS 
375 His6-TacA  
(Joshi et al., 
2015) 





(Joshi et al., 
2015) 
 EPC812 BL21DE3 plysS 
pET23b  
His6Sumo-SpbR 









(Joshi et al., 
2015) 




(Joshi et al., 
2015) 
 EPC970 BL21DE3 plysS 
pET23b  
His6Sumo-RcdA 
(Joshi et al., 
2015) 
 EPC1000 TOP10 pET23b  
His6Sumo-RcdA 
(Joshi et al., 
2015) 
 EPC1037 BL21DE3 plysS 
pET23b  
His6Sumo-PopA 
(Joshi et al., 
2015) 























We thank the Chien, Strieter, Stratton and Serio labs for helpful comments and 
discussions. We thank A. Kosowicz, W. Chowdhury and M. Sutherland for their prior 
work on the RcdA variants and generating plasmids. The anti-SpbR, anti-RcdA, and 
anti-FtsZ antibodies were graciously provided by G. Bowman, L. Shapiro, and E. Goley. 
This project was supported by funds from the NIH (R35GM130320). N.K. was supported 
in part through the Biotechnology Training Program (NIH T32GM108556). SEC-MALS, 
ITC, AUC, and MST data were obtained at the University of Massachusetts Biophysical 
Characterization Facility. HDX-MS data were obtained at the University of 
Massachusetts Mass Spectrometry Facility. Special thanks to Lizz Bartlett in the IALS 
Biophysical Instrumentation Facility for her help with AUC experimental setup and data 














1. Mahmoud, S.A., and Chien, P. (2018). Regulated Proteolysis in Bacteria. 
Annu. Rev. Biochem. 87, 677–696. 
2. Truscott, K.N., Bezawork-Geleta, A., and Dougan, D.A. (2011). Unfolded 
protein responses in bacteria and mitochondria: A central role for the ClpXP 
machine. IUBMB Life 63, 955–963. 
3. Olivares, A.O., Baker, T.A., and Sauer, R.T. (2018). Mechanical Protein 
Unfolding and Degradation. Annu. Rev. Physiol. 80, 413–429. 
4. Sauer, R.T., and Baker, T.A. (2011). AAA+ Proteases: ATP-Fueled 
Machines of Protein Destruction. Annu. Rev. Biochem. 80, 587–612. 
5. Kuhlmann, N.J., and Chien, P. (2017). Selective adaptor dependent protein 
degradation in bacteria. Curr. Opin. Microbiol. 36, 118–127. 
6. Levchenko, I., Seidel, M., Sauer, R.T., and Baker, T.A. (2000). A Specificity-
Enhancing Factor for the ClpXP Degradation Machine. Science (80-. ). 289, 
2354 LP-2356. 
7. Chien, P., Grant, R.A., Sauer, R.T., and Baker, T.A. (2007). Structure and 
Substrate Specificity of an SspB Ortholog: Design Implications for AAA+ 
Adaptors. Structure 15, 1296–1305. 
8. Flynn, J.M., Levchenko, I., Sauer, R.T., and Baker, T.A. (2004). Modulating 
substrate choice: the SspB adaptor delivers a regulator of the 




degradation. Genes Dev. 18, 2292–2301. 
9. Joshi, K.K., Bergé, M., Radhakrishnan, S.K., Viollier, P.H., and Chien, P. 
(2015). An Adaptor Hierarchy Regulates Proteolysis during a Bacterial Cell 
Cycle. Cell 163, 419–431. 
10.  Iniesta, A.A., McGrath, P.T., Reisenauer, A., McAdams, H.H., and Shapiro, 
L. (2006). A phospho-signaling pathway controls the localization and activity 
of a protease complex critical for bacterial cell cycle progression. Proc. Natl. 
Acad. Sci. U. S. A. 103, 10935–10940. 
11.  Lau, J., Hernandez-Alicea, L., Vass, R.H., and Chien, P. (2015). A 
Phosphosignaling Adaptor Primes the AAA+ Protease ClpXP to Drive Cell 
Cycle-Regulated Proteolysis. Mol. Cell 59, 104–116. 
12.  McGrath, P.T., Iniesta, A.A., Ryan, K.R., Shapiro, L., and McAdams, H.H. 
(2006). A Dynamically Localized Protease Complex and a Polar Specificity 
Factor Control a Cell Cycle Master Regulator. Cell 124, 535–547. 
13. Quon, K.C., Marczynski, G.T., and Shapiro, L. (1996). Cell Cycle Control by 
an Essential Bacterial Two-Component Signal Transduction Protein. Cell 
84, 83–93. 
14. Reisenauer, A., Quon, K., and Shapiro, L. (1999). The CtrA Response 
Regulator Mediates Temporal Control of Gene Expression during the 
Caulobacter Cell Cycle. J. Bacteriol. 181, 2430 LP – 2439. 
15. Jenal, U., and Fuchs, T. (1998). An essential protease involved in bacterial 




16. Ozaki, S., Schalch-Moser, A., Zumthor, L., Manfredi, P., Ebbensgaard, A., 
Schirmer, T., and Jenal, U. (2014). Activation and polar sequestration of 
PopA, a c-di-GMP effector protein involved in Caulobacter crescentus cell 
cycle control. Mol. Microbiol. 94, 580–594. 
17. Duerig, A., Abel, S., Folcher, M., Nicollier, M., Schwede, T., Amiot, N., 
Giese, B., and Jenal, U. (2009). Second messenger-mediated 
spatiotemporal control of protein degradation regulates bacterial cell cycle 
progression. Genes Dev. 23, 93–104. 
18. Smith, S.C., Joshi, K.K., Zik, J.J., Trinh, K., Kamajaya, A., Chien, P., and 
Ryan, K.R. (2014). Cell cycle-dependent adaptor complex for ClpXP-
mediated proteolysis directly integrates phosphorylation and second 
messenger signals. Proc. Natl. Acad. Sci. 111, 14229 LP – 14234. 
19. Wang, H., and Bowman, G.R. (2019). SpbR overproduction reveals the 
importance of proteolytic degradation for cell pole development and 
chromosome segregation in Caulobacter crescentus. Mol. Microbiol. 111, 
1700–1714. 
20. Biondi, E.G., Skerker, J.M., Arif, M., Prasol, M.S., Perchuk, B.S., and Laub, 
M.T. (2006). A phosphorelay system controls stalk biogenesis during cell 
cycle progression in Caulobacter crescentus. Mol. Microbiol. 59, 386–401. 
21. Bhat, N.H., Vass, R.H., Stoddard, P.R., Shin, D.K., and Chien, P. (2013). 
Identification of ClpP substrates in Caulobacter crescentus reveals a role 





22. Taylor, J.A., Wilbur, J.D., Smith, S.C., and Ryan, K.R. (2009). Mutations 
that Alter RcdA Surface Residues Decouple Protein Localization and CtrA 
Proteolysis in Caulobacter crescentus. J. Mol. Biol. 394, 46–60. 
23. Joshi, K.K., Sutherland, M., and Chien, P. (2017). Cargo engagement 
protects protease adaptors from degradation in a substrate-specific 
manner. J. Biol. Chem. 292, 10973–10982. 
24. Konermann, L., Pan, J., and Liu, Y.-H. (2011). Hydrogen exchange mass 
spectrometry for studying protein structure and dynamics. Chem. Soc. Rev. 
40, 1224–1234. 
25. Chalmers, M.J., Busby, S.A., Pascal, B.D., West, G.M., and Griffin, P.R. 
(2011). Differential hydrogen/deuterium exchange mass spectrometry 
analysis of protein-ligand interactions. Expert Rev. Proteomics 8, 43–59. 
26. Aretakis, J.R., Gega, A., and Schrader, J.M. (2019). Absolute 
Measurements of mRNA Translation in Caulobacter crescentus reveal 
Important Fitness Costs of Vitamin Scavenging. mSystems 4, e00170-19. 
27. Brilli, M., Fondi, M., Fani, R., Mengoni, A., Ferri, L., Bazzicalupo, M., and 
Biondi, E.G. (2010). The diversity and evolution of cell cycle regulation in 
alpha-proteobacteria: a comparative genomic analysis. BMC Syst. Biol. 4, 
52. 
28. Pini, F., De Nisco, N.J., Ferri, L., Penterman, J., Fioravanti, A., Brilli, M., 




Cycle Control by the Master Regulator CtrA in Sinorhizobium meliloti. PLOS 
Genet. 11, e1005232. 
29. Kim, H.W., Eletsky, A., Gonzalez, K.J., van der Wel, H., Strauch, E.-M., 
Prestegard, J.H., and West, C.M. (2020). Skp1 Dimerization Conceals Its 
F-Box Protein Binding Site. Biochemistry 59, 1527–1536. 
30. Brown, B.L., Vieux, E.F., Kalastavadi, T., Kim, S., Chen, J.Z., and Baker, 
T.A. (2019). N domain of the Lon AAA+ protease controls assembly and 
substrate choice. Protein Sci. 28, 1239–1251. 
31. Gottesman, S., Roche, E., Zhou, Y., and Sauer, R.T. (1998). The ClpXP 
and ClpAP proteases degrade proteins with carboxy-terminal peptide tails 
added by the SsrA-tagging system. Genes Dev. 12, 1338–1347. 
32. McGinness, K.E., Bolon, D.N., Kaganovich, M., Baker, T.A., and Sauer, 
R.T. (2007). Altered Tethering of the SspB Adaptor to the ClpXP Protease 
Causes Changes in Substrate Delivery. J. Biol. Chem. 282, 11465–11473. 
33. Bolon, D.N., Wah, D.A., Hersch, G.L., Baker, T.A., and Sauer, R.T. (2004). 
Bivalent Tethering of SspB to ClpXP Is Required for Efficient Substrate 
Delivery: A Protein-Design Study. Mol. Cell 13, 443–449. 
34. Levchenko, I., Grant, R.A., Wah, D.A., Sauer, R.T., and Baker, T.A. (2003). 
Structure of a Delivery Protein for an AAA+ Protease in Complex with a 
Peptide Degradation Tag. Mol. Cell 12, 365–372. 
35. Keiler, K.C. (2015). Mechanisms of ribosome rescue in bacteria. Nat. Rev. 




36. Rood, K.L., Clark, N.E., Stoddard, P.R., Garman, S.C., and Chien, P. 
(2012). Adaptor-dependent degradation of a cell-cycle regulator uses a 
unique substrate architecture. Structure 20, 1223–1232. 
37. Thanbichler, M., Iniesta, A.A., and Shapiro, L. (2007). A comprehensive set 
of plasmids for vanillate- and xylose-inducible gene expression in 
Caulobacter crescentus. Nucleic Acids Res. 35, e137–e137. 
38. Gibson, D.G., Young, L., Chuang, R.-Y., Venter, J.C., Hutchison, C.A., and 
Smith, H.O. (2009). Enzymatic assembly of DNA molecules up to several 


















Hydrogen-Deuterium Exchange Mass Spectrometry Reveals Determinants 
for PopA-Dependent Functions 
Nathan J Kuhlmann1, Peter Chien1* 
 
Affiliations: 
1Department of Biochemistry and Molecular Biology, Molecular and Cellular 
















Regulated protein degradation is aided by specificity factors called adaptor 
proteins that alter the substrate selection of their respective proteases. In 
Caulobacter crescentus, the PopA adaptor, along with two other adaptors, 
controls the regulated degradation of the replication inhibitor, CtrA. In doing so, 
PopA must make interactions with the RcdA adaptor and the small molecule, 
cyclic-di-GMP, to deliver CtrA to ClpXP during the cell cycle. However, how PopA 
coordinates interactions with RcdA and CtrA to perform its delivery function is 
poorly understood. Here, we provide mechanistic details into the determinants of 
PopA responsible for RcdA, CtrA and cdG interactions using statistically filtered 
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) experiments. We 
map the surfaces involved in the binary PopA-RcdA and PopA-cdG complex and 
the surfaces involved in the PopA-RcdA-CtrA ternary complex and show that this 
ternary complex forms in vitro. We show that, in solution, PopA must facilitate 
conformational changes throughout the protein through cdG binding to facilitate 
its functional state while degrading CtrA. Our findings suggest that RcdA and 
CtrA share nonoverlapping surfaces on PopA and determine that PopA can 
accommodate both CtrA and RcdA interactions as a monomer. This work 
provides mechanistic insight into PopA-dependent delivery that will likely extend 






Regulated protein degradation controls many key aspects of physiology and is 
essential for proper homeostasis. In Bacteria, AAA+ (ATPases with Associated 
Activities) proteases degrade misfolded and native substrates to maintain proper 
homeostasis and regulate cell-cycle progression (Mahmoud et al., 2018). The 
Clp family of proteases, which include the protease ClpXP, are essential for 
degrading proteins necessary for maintaining normal cell physiology in bacteria 
and eukaryotic organelles (Truscott et al., 2011, Olivares et al., 2018). AAA+ 
protease work by using two functional modules: an oligomeric unfoldase which 
recognizes a short degradation motif and consequentially unfolds proteins into 
the peptidase module, which non-specifically cleaves proteins into smaller 
peptide fragments (Sauer and Baker, 2011).  
To properly regulate the specificity of their targets, bacterial proteases use 
accessory factors, or adaptors, to control the specificity of the protease 
(Kuhlmann et al., 2017). Adaptors can either act as scaffolds by increasing the 
local concentration of substrate through tethering or by priming the protease by 
binding to the unfoldase module and promoting recognition of substrates. In the 
alpha-proteobacterium Caulobacter crescentus, a hierarchy of adaptors controls 
protein degradation during cell-cycle progression and development (Joshi et al., 
2015). In this proteolytic pathway, the CpdR binds to ClpX, activating it and 
recruiting a specific set of substrates (Iniesta et al., 2006, Lau et al., 2015). The 




set of substrates through direct interactions with its cargo (McGrath et al., 2006, 
Joshi et al., 2015, Kuhlmann et al., 2021). Finally, the third adaptor, PopA, 
interacts with RcdA and the small molecule cyclic-di-GMP (cdG) to deliver the 
replication inhibitor and master regulator of the Caulobacter cell cycle, CtrA 
(Quon et al., 1996, Duerig et al., 2009, Ozaki et al., 2014). PopA was discovered 
to be a gene duplication product of the diguanylate cyclase enzyme PleD through 
functional characterization of Caulobacter crescentus proteins involved in cdG 
turnover (Duerig et al., 2009). While PopA can bind cdG specifically, it lacks 
diguanylate cyclase (DGC) activity, suggesting that PopA evolved from PleD to 
serve a different function (Duerig et al., 2009). Through bioinformatic 
comparisons with PleD, it was found through homology modeling that PopA 
shares a common response regulator fold like PleD and other DGC enzymes 
found in other bacteria, such as WspR (De et al., 2009) and DgcB (Meek et al., 
2019). The conserved response regulator structure uses input receiver domains, 
where phosphorylation of a conserved site shifts the response regulator from an 
inactive conformation to an active conformation (Gao et al., 2019). For DGC 
enzymes, phosphorylation and cdG binding to the GGDEF domain gate the 
catalytic behavior of the enzyme. For PleD, phosphorylation and cdG binding 
allow for dimerization of the PleD enzyme necessary for catalytic activity 
(Wassman et al., 2007, Chan et al., 2004). Surprisingly, despite evolving from the 
PleD gene, PopA is not regulated by phosphorylation (Ozaki et al., 2014) but 




Furthermore, PopA can interact with RcdA without its GGDEF domain, 
suggesting a role for its receiver domains in facilitating protein-protein 
interactions (Ozaki et al., 2014). It has been suggested that PopA can forms 
dimers in the presence of cdG in vivo (Wang et al., 2021). While both PopA and 
RcdA are necessary for delivery of CtrA during the Caulobacter cell cycle, the 
mechanism by which PopA interacts with RcdA and CtrA to promote delivery 
remains unclear.  
Here, we provide detailed characterization of the PopA-RcdA-CtrA ternary 
complex and the surfaces on PopA responsible for each binary interaction using 
hydrogen-deuterium exchange and statistical filtering of each dataset. We found 
that different peptides were protected across each dataset in the ternary complex 
versus each binary complex and provide proposed interaction surfaces arising 
from our HDX-MS data. We confirm that RcdA, PopA and CtrA form a ternary 
complex only in the presence of cdG. We show that, in solution, PopA must 
facilitate conformational changes throughout PopA through cdG binding to 
facilitate its functional state while degrading CtrA and that, surprisingly, PopA 
binds CtrA as a monomer only in the presence of cdG. Our findings suggest that 
RcdA and CtrA share nonoverlapping surfaces on PopA and that PopA binds 







RcdA, CtrA and PopA form a Ternary Complex 
We began our studies by performing interaction studies to determine if PopA can 
interact with RcdA and CtrA to form a ternary complex. PopA and RcdA interact 
directly without cdG, where a monomer of PopA binds a monomer of RcdA 
(Duerig et al., 2009, Smith et al., 2014, Kuhlmann et al., 2021) and it is 
suggested PopA can interact with CtrA only in the presence of cdG (Smith et al., 
2014). We decided to perform a nickel pulldown experiment using a 6xHis tagged 
CtrA (His6-CtrA) to assay for PopA-RcdA-His6-CtrA ternary complex formation. 
We replicated the results from (Smith et al., 2014) showing that PopA can only 
be pulled down by CtrA in the presence of cdG (Figure 3.1A). In the presence of 
RcdA, all three proteins were present in the elution fraction, suggested binding of 
RcdA and His6-CtrA to PopA simultaneously (Figure 3.1B). Interestingly, cdG 
does not affect RcdA’s affinity for PopA, suggesting that the binding of cdG to 
PopA affects CtrA interactions independently of RcdA (Figure 3.2). Because 
PopA might form a dimer in presence of cdG, we asked whether there might be 
another role for cdG in facilitating PopA-CtrA interactions and whether CtrA and 
RcdA might share a common interaction surface on PopA.   
Mapping of the RcdA-PopA Interaction Surface 
We next performed Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-




proteins to map out the protein-protein interfaces of each binary complex and the 
PopA-CtrA-RcdA ternary complex (Konermann et al., 2011, Chalmers et al., 
2011). We began by mapping out the surface on PopA masked by RcdA binding. 
Our initial PLGS searches yielded over 4,000 peptides, making interpretation of 
our data challenging. Using a statistical filtering program designed to provide 
more rigorous filtering of HDX-MS data (Hageman and Weis, 2019, Lau et al., 
2020), we identified and narrowed our scope of peptides that showed the most 
protection across the time course of the HDX-MS assay. Our initial HDX data 
showed coverage across the entire protein, but we specifically looked for regions 
that showed up as the most protected after providing a p-value cutoff filter of 
0.05. Peptides spanning residues 127-169, residues 267-275, and residues 296-
302 showed the strongest protection on PopA in the presence of RcdA after 
application of statistical filtering in the Deuteros software (Figure 3.3A). Using 
Phyre2 fold prediction, we generated a homology model of PopA using the 
inactivated crystal structure of PleD as a model (Chan et al., 2004). We took the 
statistically filtered HDX data and mapped the protected and more exposed 
regions onto the modeled structure (Figure 3.3B). The protected regions formed 
a distinct surface on PopA that span through the last 4 amino acids of the 1st 
receiver domain through most of the second receiver domain. Our data is 
consistent with the 2nd receiver domain of PopA comprising most of the 
interaction surface in the PopA-RcdA interaction. Individual peptide uptake plots 




whether the 1st receiver domain is sufficient to bind RcdA, which has been 
previously suggested by BATCH, we made a 1st receiver domain truncation (1-
117) that lacked the second receiver domain and tested whether this domain 
would be able of binding RcdA by size-exclusion chromatography coupled with 
multi-angle light scattering (SEC-MALS). Consistent with the second receiver 
domain being needed for RcdA-PopA interactions, we did not see any binding of 
this truncation construct by SEC-MALS (Figure 3.4). Interestingly, this construct 
could compete off GFP-DBDTacA degradation, a direct test of RcdA-mediated 
degradation (A.14). To confirm our original HDX data and to ensure that the 
interaction surface on PopA does not change for RcdA when cdG is bound, we 
performed SEC-MALS with PopA incubated with RcdA and cdG and did a 
pairwise state comparison in Deuteros to PopA incubated with cdG. Consistent 
with our PopA-RcdA HDX results, we saw a large cluster of protected peptides 
primarily in the 2nd receiver domain, supporting a model where the PopA-RcdA 
interaction surface consists of the 2nd receiver domain (Figure 3.5). 
Cyclic-di-GMP binding allows for PopA-CtrA interactions by 
Conformational Changes in PopA 
We next tested to see what surfaces were protected on PopA in the presence of 
cdG, the small molecule necessary for CtrA delivery (Duerig et al., 2009). It has 
been suggested that cdG helps PopA forms dimers in vivo (Wang et al., 2021), 
however, there lacks strong evidence for PopA dimerization in vitro. We took into 




conformation of PopA in the presence of cdG, as the active conformation of PleD 
when it dimerizes in the presence of cdG is different than the inactive 
conformation. In the presence of cdG, we saw much of the PopA protein become 
protected from deuterium uptake over the course of the assay (Figure 3.6A). We 
looked for specific interfaces that could function as the dimer interface between 
two copies of the modeled PopA structure based on the inactive and active 







Figure 3.1: His6-CtrA Nickel Pulldown Assay 
A) SDS-Page gels of Nickel Pulldown assay of His6-CtrA alone, PopA alone 
and PopA + CtrA in the presence and absence of cdG. 10µM PopA or 
His6-CtrA were incubated with 50µL of pre-equilibrated Ni-NTA resin. The 
resin was washed and eluted as described in the methods. B) SDS-Page 
gels of Nickel Pulldown assay of His6-CtrA alone, RcdA alone and His6-
CtrA + RcdA, and His6-CtrA + RcdA and PopA in the presence of cdG. 
10µM PopA, His6-CtrA or RcdA were incubated with 50µL of pre-
equilibrated Ni-NTA resin. The resin was washed and eluted as described 






























Figure 3.2: RcdA Interacts with the Second Receiver Domain of PopA by 
HDX-MS 
A) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from 
the each timepoint are highlighted, with peptides showing lower 
statistical HDX change in blue, and higher statistical HDX change in 
red. Insignificantly changing peptides are in grey. Each domain of 
PopA is annotated under the residue number. A significance filter of  
ɑ = 0.05 was used. B) Mapped HDX changes from the Woods plot 
onto a SWISS-MODEL modeled PopA structure based on the 
inactivated crystal structure of PleD (PDB code: 1W25) for the 60 
minute timepoint. Highlighted surfaces, peptides and regions on PopA 
are shown in each depiction C) Selected peptides from the second 
receiver domain that are highly protected upon RcdA binding from the 










Figure 3.3: RcdA binds PopA and PopA-cdG with Similar Affinity 
A) Fluorescence polarization binding curve of a fluorescently labeled RcdA 
with increasing concentrations of PopA. 100nM RcdA was incubated 
with up to 40uM PopA. Polarization data was fit to a single site binding 
model as described in the methods. B) Fluorescence polarization 
binding curve of a fluorescently labeled RcdA with increasing 
concentrations of PopA. 100nM RcdA was incubated with up to 40uM 








Figure 3.4: The First Receiver Domain is Insufficient to bind RcdA by SEC-
MALS 
SEC-MALS analysis of PopARD-1 (1-117) incubated with RcdA by SEC-MALS. 
The first receiver domain is incapable of forming a higher-order complex with 
RcdA, as evidenced by the lack of a peak shift in the chromatogram. Surprisingly, 












Figure 3.5: RcdA Interacts with the Second Receiver Domain of PopA when 
cdG is present 
Hybrid statistical Woods’s plot of filtered HDX peptides for PopA-RcdA-cdG 
compared to PopA-cdG. Peptides from the 1 minute, 10 minute and 60 
minute timepoints are highlighted, with peptides showing lower statistical 
HDX change in blue, and higher statistical HDX change in red. 
Nonsignificant changing peptides are in grey. A significance filter of ɑ = 
0.05 was used. This experiment shows that the PopA-RcdA interaction 




































Figure 3.6: CdG Binding Causes Conformational Changes in PopA 
A) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from the 
1 minute, 10 minute and 60 minute timepoints are highlighted, with 
peptides showing lower statistical HDX change in blue, and higher 
statistical HDX change in red. Nonsignificant changing peptides are in 
grey. B) Mapped HDX changes from the Woods plot onto a SWISS-
MODEL modeled PopA structure based on the inactivated crystal 
structure of PleD (PDB code: 1W25) for the 60 minute timepoint. 
Highlighted surfaces, peptides and residues in each patch are shown in 
each graphical representation. The C-terminal patch that is highlight in 
the PopA-cdG HDX data is highlighted in gold. C) Selected peptides 












We first checked to see if residues in the primary I site of the GGDEF domain 
were protected in our dataset, as mutations in this site disrupt cdG binding and 
this was a good indication that PopA and cdG were binding in our experiments. 
Consistent with this data, we saw protection from deuterium in the primary I-site 
spanning over R357, the residue shown to be necessary for cdG binding (Figure 
3.2A, Duerig et al., 2009). Even with the most stringent statistical cutoffs (p = 
0.001) selective peptides in the I-site were protected from deuterium exchange. 
Next, we looked for any interfaces that might potentially form a dimer in the 
active modeled structure. Work from (Ozaki et al., 2014) identified the dimer 
interface forming between the rec1 and rec2 domains of PopA in this model, 
which was primarily formed by a salt bridge comprised of residues R118, E125 
and E129. However, mutations in these residues did not affect CtrA delivery, 
which is dependent on PopA-cdG interactions (Ozaki et al., 2014). This suggests 
that the rec1-rec2 dimer interface model based on the PleD crystal structure 
does not contain any potential dimer interface of PopA. Consistent with this, 
these residues were not protected in any timepoint throughout the HDX-MS 
experiment (Figure 3.6A). There did not seem to be any interfaces formed in both 
the inactive and active state modeled structure of PopA that could lend itself to a 
dimer interface. At the concentrations used in our HDX experiments (5uM PopA 
and 40uM cdG), we wanted to see if our HDX data could be explained by 
changes in the PopA structure rather than dimerization. We tested to see if PopA 




cdG that fully stimulate CtrA degradation, which we found to be at its maximal 
degradation rate at 10uM of cdG (Figure 3.7)  
 
Figure 3.7: Activation curve of GFP-CtrA Degradation by cdG 
Kactivation curve of GFP-CtrA degradation in the presence of varying 
concentrations of cdG and 5uM PopA, 3uM RcdA, 3uM CpdR, 0.2uM ClpX, 
0.4uM ClpP and 1X ATP Regeneration mix. Data was fit to a modified version of 
the Michaelis-Menten equation to account for background degradation as noted 








Figure 3.8: Sedimentation Velocity-AUC of PopA in the Presence of cdG 
A) Sedimentation-Velocity AUC Distribution of 25µM PopA. The distribution 
statistics and fitted parameters are listed next to the graph. B) 
Sedimentation-Velocity AUC Distribution of 5µM PopA in the presence of 
40µM cdG. The distribution statistics and fitted parameters are listed next 








Consistent with this, we did not see dimerization of PopA at fully stimulatory 
concentrations by AUC and no evidence of dimerization at high concentrations of 
PopA alone without cdG present (Figure 3.8). Surprisingly, the frictional ratio of 
PopA was 1.9, indicated an elongated conformation like that of an antibody. This 
ratio did not change upon cdG addition (Figure 3.8B). Therefore, the deuterium 
protection and CtrA binding in the presence of cdG is more likely explained by 
conformational changes in PopA upon cdG binding to promote ctrA binding. We 
wanted to see if CtrA affected the dimerization state of PopA upon binding, which 
we could not do by AUC due to limitations in the absorbance optics of the 
instrument. To do this, we used SEC-MALS to assess the oligomerization state 
of PopA upon CtrA binding. We ran both CtrA, PopA and RcdA on SEC-MALS 
with buffer that contained cdG. CtrA ran as a 27kDa monomer by SEC-MALS, 
while PopA ran as a 44kDA monomer. As predicted by previous experiments, the 
RcdA + PopA complex ran as a 59kDA complex (Figure 3.9A). We next ran PopA 
and CtrA together and found the complex to be approximately 70kDa, close to a 
predicted mass of a monomer of PopA bound to a monomer of CtrA (Figure 
3.9B). We next tested to see if we could see the ternary complex being formed 
when we added RcdA to a PopA-CtrA reaction. The chromatography peak that 
formed did not scatter light and ran as a smear (Figure 3.9B), making it 
challenging to determine the stoichiometry of the ternary complex. Combined 
with the fact that the Kactivation constant for cdG-stimulated CtrA delivery is ~1.5uM 




PopA structure upon binding to accommodate CtrA interactions. We analyzed 
our HDX further to see if any specific domains or regions on PopA particularly 
changed upon cdG binding. The region with the most protected peptides was 
centered around residues 410-441, the end of the C-terminus of PopA (Figure 
3.5B). One possible model is that proper orientation of the C-terminus of PopA is 
required for CtrA binding, explaining why this region is highly protected upon cdG 
binding. Taken together, our data favors a model where PopA dimerization by 
cdG is not necessary for CtrA delivery but rather cdG binding is required for 
priming PopA for CtrA interactions by conformational changes that provide a 









Figure 3.9: PopA and CtrA form a Monomer:Monomer Stoichiometry by 
SEC-MALS 
A) SEC-MALS traces of RcdA, PopA, CtrA or different pairwise 
combinations of each protein in buffer not containing cdG. Each protein 
was run at 50uM alone or together. The dotted lines indicate the 
weight-averaged mass from the light scattering detector of each 
protein or protein complex.  B) SEC-MALS traces of RcdA, PopA, CtrA 
or different pairwise combinations of each protein in buffer containing 
0.5mM cdG that was freshly prepared. Each protein was run at 50uM 
alone or together. The dotted lines indicate the weight-averaged mass 





CtrA interacts at a Nonoverlapping Surface on PopA  
We concluded our HDX studies by comparing the PopA-cdG bound complex to a 
reaction consisting of PopA, cdG and RcdA and another reaction containing 
PopA, cdG,RcdA and CtrA. Our reasoning for this was that we could only 
compare the interactions of CtrA in the context of cdG and RcdA, as both are 
necessary for CtrA delivery and RcdA also makes direct interactions with PopA 
during this delivery process. By performing these comparisons in the same HDX 
experimental run, we can compare the peptide uptake and see which regions are 
protected in the presence of CtrA specifically after subtracting the contributions 
from cdG and RcdA. Most of the surface that was identified in the PopA-RcdA 
dataset did not change upon addition of CtrA, suggested that no further 
protection of this region occurs in the presence of CtrA as was seen for the 
PopARcdAcdG dataset (Figure 3.10A). However, there was some residues and 
patches that were shared with the RcdA dataset, such as regions 155-162 and 
266-281 (Figure 3.3A, 3.8A). Interestingly, there was a surface that was primarily 
unique to the CtrA dataset, spanning from residues 255-295 and 323-341 (Figure 
3.8A,B). We have shown peptides in the region showing strong protection 
through peptide uptake plots (Figure 3.8C). This region consists of the loop 
connecting the second receiver domain and the GGDEF domain and forms a 
surface ideal for binding (Figure 3.8B). This surface shares some overlap with 
the surface proposed in the RcdA dataset but does not grossly overlap with the 




simultaneously and provides supporting evidence for ternary complex formation 
and different surfaces being involved in the RcdA and CtrA interactions with 
PopA. Taken together, the peptides protected in the PopARcdAcdGCtrA dataset 
are widely unique to the addition of CtrA compared to the PopARcdAcdG 
dataset. Considering both RcdA and CtrA appear to interact with a monomer of 
PopA and can form a ternary complex, it is logical for CtrA and RcdA to use 
nonoverlapping interfaces on PopA to facilitate ternary complex formation. We 
designed a fluorescence polarization-based competition assay to see if CtrA can 
compete off RcdA-PopA interactions using a constitutively monomeric variant of 
RcdA (RcdA L82E) labeled with Fluorescin-5-Maleimide (Kuhlmann et al., 2021). 
Upon incubation of L82E with PopA, we see a characteristic increase in 
polarization (Figure 3.11A). Adding an excess of unlabeled RcdA competes off 
L82E-PopA interactions by formation of the RcdA-PopA complex, causing the 
polarization to return to unbound levels. We tested for competition of L82E-PopA 
in the presence of cdG and CtrA and found that CtrA could not compete off 
L82E-PopA interactions by formation of the PopA-cdG-CtrA complex (Figure 
3.11A). This data suggests that CtrA binding does not overlap with RcdA-PopA 








Figure 3.10: HDX Data from PopA-RcdA-CtrA Ternary Complex 
B) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from 
each timepoint are shown, with peptides showing lower statistical HDX 
change in blue, and higher statistical HDX change in red. 
Nonsignificant changing peptides are in grey. This data is the PopA-
RcdA-CtrA-cdG reaction subtracted from the PopA-RcdA-cdG reaction. 
B) Mapped HDX changes from the Woods plot onto a SWISS-MODEL 
modeled PopA structure based on the inactivated crystal structure of 
PleD (PDB code: 1w25). Highlighted in gold is the Rec1-2 stem that 
could form a potential surface for CtrA binding. C) Selected peptides 






Figure 3.11: Fluorescence Polarization CtrA Competition Assay 
A) Fluorescence polarization CtrA competition experiment. Fluorescently 
labeled RcdA L82E was incubated with 20uM PopA, RcdA, cdG or 
CtrA or in varying combinations. The polarization values were then 
read. B) Cartoon illustrated the workflow of the fluorescence 
polarization experiment with the different experimental outcomes. 
Competition of CtrA leads to a release of the unbound RcdA 
fluorophore, causing the polarization to return to unbound levels. 
Interaction of CtrA at a different interaction site will not cause the 




Taken together, our data suggests a model where the delivery of CtrA is 
regulated by the formation of a ternary complex of RcdA, cdG, PopA and CtrA 
(Figure 3.12). The interaction between PopA and CtrA is gated by cdG binding, 
which initiates conformational changes that allow PopA to accommodate CtrA 
binding to monomers of PopA. RcdA also binds monomers of PopA, primarily 
through interactions with the second receiver domain of PopA. We propose that 
CtrA and RcdA interact on nonoverlapping surfaces as shown by HDX and 
fluorescence polarization studies and formation of this complex is necessary for 
















As a monomer, PopA is capable of binding RcdA, cyclic-di-GMP, and CtrA 
simultaneously. RcdA-PopA interactions primarily take place at the 2nd receiver 
domain, while CtrA interacts with PopA on a different interface. Proper CtrA 
delivery is dependent on cdG binding to PopA, which induces conformational 
changes that allow for CtrA binding. The formation of this ternary complex is 
needed for proper CtrA degradation by the ClpXP protease. 
3.4 Discussion 
Adaptor mediated degradation is critical for bacteria for coordinating stress 
responses and cellular transitions. Because of CtrA critical importance in 
regulating the bacterial cell cycle, understanding the mechanisms of binding and 
complex formation will advance our understanding of CtrA’s role in 
alphaproteobacteria, such as the pathogen Brucella abortus (Francis et al., 
2017). Our HDX and biochemical studies reveal how PopA accommodates RcdA 
and CtrA interactions and how cdG gates PopA-CtrA interactions. RcdA and CtrA 
do not appear to interact on similar interfaces on the PopA structure.  
PopA is a unique protease adaptor in Caulobacter in that it is not degraded like 
other adaptors such as CpdR, RcdA and SspB (Joshi et al., 2017), is regulated 
by the binding of a small molecule to gate its CtrA delivery function and is limited 
to only a small subset of alphaproteobacteria closed related to Caulobacter (Brilli 
et al., 2010). Interestingly, CpdR, RcdA and CtrA are present in Brucella abortus, 
while PopA is not present (Francis et al., 2017). How Brucella abortus regulates 




and may be controlled by an adaptor like PopA that fulfills its function through 
RcdA interactions. In that case, the fold of PopA, which contains receiver 
domains and a cdG-binding site, contains specific elements that allow for protein-
protein interactions through the receiver domains and regulation of activity by 
cdG binding. The properties, fold, and functional characteristics of PopA serve as 
a model for how unknown adaptors may work in Brucella abortus and other 
bacteria that contain the cpdR-RcdA-ctrA pathway. PopA’s evolution from PleD 
to fulfill the specific role of delivering cargo in an adaptor-dependent manner is 
remarkable. The conversion of PleD, a cdG produced enzyme, to an adaptor that 
has no catalytic activity towards cdG highlights the importance of having PopA as 
an adaptor that adopts the general fold of a Diguanylate Cyclase yet lacks DGC 
activity. Why does PopA need to be able to bind cdG to fulfill its function? 
Published literature about DGC’s show that cdG binding shifts the conformation 
from an inactive state to an active state and this promotes dimerization of the 
enzyme. However, for PopA, this dimerization is very weak and it does not need 
to dimerize to promote CtrA binding and delivery. Could there be a role for PopA 
dimerization in delivering other PopA-dependent cargo? Recent literature 
suggests that there could be a link between PopA dimerization and the protein 
SmrF (Wang et al., 2021). One potential model is that PopA adopts both 
monomeric and dimeric states to accommodate the delivery of different cargo, 




the link between cdG and PopA dimerization and how cdG tightly regulates 
PopA-dependent activity, regardless of the oligomerization state it is in. 
3.13 Materials and Experimental Procedures 
Protein Expression and Purification. BL21(DE3) pLYS or X90 cells with 
expression plasmids for different proteins were grown at 37°C to an OD600 of 0.4-
0.6, then induced with 0.4mM IPTG for 3-4 h. Induced cells were then centrifuged 
at 7,000g for 10 minutes and resuspended in buffer containing 50mM Tris pH 8.0, 
300mM NaCl, 10mM imidazole,  0% glycerol, 5mM β-mercaptoethanol and 
100mM PMSF and frozen at -80°C until further use. Cells were lysed using a 
Microfluidizer system (Microfluidics, Newton, MA). The clarified lysate was bound 
over a Ni-NTA column for affinity purification. H6SUMO-tagged proteins were 
cleaved by Ulp1-his protease (36). Proteins were then purified using size exclusion 
and anion-exchange chromatography using Sephacryl 200 16/60 and MonoQ 5/50 
columns. ClpX and ClpP were purified as outlined in (9). Detailed purification 
protocols are available upon request.  
Cloning and Molecular Biology. PopA variants and trunctations were cloned 
using around-the-horn cloning by amplifying the appropriate domains using 
pET23SUMO-PopA as a template.  
Fluorescence Polarization and Maleimide Labeling. Purified RcdA or RcdA 
mutants were labeled with Fluorescin-5-Maleimide (Thermo ScientificTM). Purified 




7.0, 150mM NaCL, 2mM TCEP). Fluorescin-5-Maleimide was dissolved in DSMO 
and added to protein at a 20-fold molar excess to cysteine. Labeling reactions were 
completed at 4°C overnight. Free dye was removed using a PD-MidiTrap column 
(GE Healthcare) and Amicon Ultra-15 Centrifugal Filter Units in a buffer containing 
20mM HEPES pH 8.5, 100mM KCL, 10mM MgCl2 and 0.05% Tween. 
Confirmation of protein labeling was verified using a Typhoon imaging system (GE 
Healthcare). The labeled protein was aliquoted, and flash frozen at -80°C.  
Fluorescence polarization binding experiments were performed with 100 nM 
labeled RcdA or RcdA L82E and varying concentrations of PopA, CtrA or cdG. The 
binding reaction was incubated at 25°C for 1hr to reach equilibrium. Polarization 
measurements were read from 40uL of these mixtures using opaque black 384-
well plates using a SpectraMax M5 plate reader (Molecular Devices) with excitation 
and emission wavelengths set at 460 and 540, respectively. Equilibrium binding 
constants were calculated by fitting the polarization data using GraphPad Prism to 
a one site, total and nonspecific binding equation P = Pmax*[X]/([X] + Kd) where 
Pmax is the maximum specific binding value, P is the polarization value, NS is the 
slope of linear nonspecific binding constrained to be greater than 0, and the 
background is the polarization value when [X] is 0. The NS term usually fits to 0 
and is not included in the final fit. Error bars are calculated from the standard 
deviation between replicates of experiments. All RcdA concentrations are in terms 




Size-Exclusion Chromatography with Multi-Angle Light Scattering. Each 
protein complex was allowed to bind at room temperature for 45 minutes. The 
complexes were then injected onto a T Kgel™ G3000  EC column equilibrated 
in 20mM HEPES buffer, pH 7.0 with 100mM KCL and 10% glycerol (Tosoh 
Biosciences) at room temperature. The SEC column was coupled to an 18-angle 
light scattering detector (DAWN HELEOS-II) and a refractive index detector 
(Optilab T-rEX) (Wyatt Technology). Data was collected every second and the flow 
rate was set to 0.5 mL/min. Data analysis was carried out using the program 
ASTRA (Wyatt Technology). Monomeric bovine serum albumin (BSA; Sigma) was 
used for calibration of the light scattering detectors and general data quality 
control. Measurements were taken at 25°C. The light scattering data was collected 
across a window containing the entire chromatographic peak for a full distribution 
of molecular weights, shown underneath each chromatogram.  
Hydrogen-Deuterium Exchange Mass Spectrometry. Hydrogen-deuterium 
exchange was measured on a Synapt G2Si high definition mass spectrometer 
(Waters). Deuterium exchange and quenching steps were performed using an 
automated HDX robotics platform (Waters). Samples were diluted 1:16 in D2O-
containing buffer containing 0.1 mM K2HPO4 to final concentrations as specified in 
the figure legends. Deuterium exchange was allowed to take place for 0, 1, 10 and 
60 minutes at 25°C, with staggered starts for each dilution reaction. After all 
reactions were completed, aliquots were removed and diluted 1:2 into cold quench 




subsequentially run over an immobilized Water ENZYMATE immobilized pepsin 
column (ID: 2.1 length: 30mm) at a flow rate of 0.15mL/min at high pressure 
(~11000 psi) for peptide digestion. Prior to HDX analysis, the quality of each 
sample was assessed using SDS-PAGE and size-exclusion chromatography. The 
output peptides were filtered using DynamX using the following filtering 
parameters: minimum intensity of 1000, minimum and maximum peptide sequence 
length of 5 and 30, respectively, minimum MS/MS products of 2, minimum products 
per amino acid of 0.25 (this can be further adjusted to prune peptides), minimum 
score of 5, and a maximum MH+ error threshold of  5 p.p.m. After analysis in 
DynamX, the data was exported as a cluster file for further analysis using 
Deuteros. For statistical analysis, filtering of peptide uptake plot data was 
performed in Deuteros (Hageman and Weis, 2019, Lau et al., 2020) using a Hybrid 
statistical model for the woods plot with ɑ = 0.02 for PopA-cdG HDX and ɑ = 0.05 
for all other experimental datasets. Mapping of Deuteros filtered data was 
performed using a pymol script exported from the Deuteros woods plot and 
mapped onto a modeled structure of PopA based on the inactive structure of PleD 
(Two independently prepared experimental replicates and labeling reactions were 
performed for each condition and averaged in the peptide uptake plots. Blank runs 
were run in between each analysis to avoid peptide carry-over. Continuous lock-
mass correction was performed using leu-enkephalin compound. Timepoints and 
analysis were randomized to ensure no biasing of results and to ensure variation. 




MSE mode at a mass resolution of 50-2000 m/z range. Identification of peptides 
and analysis of the uptake plots and charge states for each peptide were 
completed in Protein Lynx Global Server (PLGS) and the software DynamX 
(Waters). Uptake plots were plotted and created in Adobe Illustrator and in 
GraphPad Prism.  
In vitro Degradation Assays. Degradation of GFP-CtrARD+15 was monitored 
with the loss of fluorescence over time as described previously (Smith et al., 2014). 
The concentrations of each protein used in the reactions were as follows unless 
otherwise noted: 3μM RcdA, 3μM RcdA(L82E), 2μM CpdR, 0.2μM ClpX6, 0.4μM 
ClpP14, 2μM GFP-CtrARD+15, 5mM ATP. GFP-CtrARD+15 with cdG curves were 
fit to a modified hyperbolic equation with the form of:  Y = ((Vmax * [RcdA]) / (Kact 
+ [RcdA])) + A, where A is a baseline constant, or to the Michaelis-Menten equation 
using GraphPad Prism. 
Sedimentation Velocity Analytical Ultracentrifugation. Sedimentation Velocity 
experiments were completed using a Beckman ProteomeLab XL-1 Analytical 
Ultracentrifuge (Beckman). Samples were diluted into 20 mM HEPES pH 8.5, 
100mM KCl, 10% glycerol at the concentrations indicated in the figure legends. 
The samples were spun at 55,000 g overnight at 25°C. The ρ and v values used 
for data fitting were determined using SEDNTERP and the amino acid sequence 
for each protein. The sedimentation velocity data was directly fit to the c(s) 




scans for each condition. The resulting distributions from each experiment were 
then plotted in GraphPad Prism.  
Ni-NTA Nickel Pulldown Assays. Nickel pulldown assays were performed using 
a Ni-NTA resin (Thermo Scientific). 50µL of Ni-NTA resin was washed and 
equilibrated with 200µL wash buffer (20mM Hepes pH 8.5, 100mM KCL, 10% 
glycerol, 30mM Imidizole). Each protein or protein mixture was combined at 200µL 
final volume and added to resin to incubate at 4°C for 2 hours. The Ni-NTA resin 
was spun down at 700xg for 2 minutes and the flowthrough samples were 
collected. 200µL of wash buffer was then added and a 700xg spin was performed 
again with a wash sample taken after the spin. Finally, 200µL of elution buffer 
(20mM Hepes pH 8.5, 100mM KCL, 10% glycerol, 300mM Imidazole) was added 
to the resin and spun down with the collection of an elution sample taken after the 











Bacterial Strains Used in This Study: 
Organism Name Description Source 






 X90 T7 recombinant 
protein expression 
From Bob Sauer 
 EPC100 dh5alpha pQE70-
his-ClpP  
(Chien et al., 
2007) 





EPC162 BL21DE3 375 
eGFP-His6-
CtrARD+15 
(Smith et al., 
2014) 
 BPC238 BL21DE3 plysS 
pET23 ClpX  
(Chien et al., 
2007) 
 EPC196 BL21DE3 plysS 
pET23b 
His6Sumo-CpdR 
(Lau et al., 2015) 
 EPC970 BL21DE3 plysS 
pET23b  
His6Sumo-RcdA 
(Joshi et al., 
2015) 
 EPC1000 TOP10 pET23b  
His6Sumo-RcdA 
(Joshi et al., 
2015) 
 EPC1037 BL21DE3 plysS 
pET23b  
His6Sumo-PopA 
(Joshi et al., 
2015) 




Kuhlmann et al., 
2021 
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Chapter 4  
Future Perspectives and Impact of Thesis on the Adaptor Field 
4.1 Overview 
In this chapter I will explore future directions that I think are worth exploring for 
the field of protease adaptors. The fundamental, mechanistic work on RcdA and 
PopA function that my thesis is focused on will allow for further dissection on the 
details of adaptor-mediated proteolysis in Caulobacter and other bacteria. The 
mechanistic work that my thesis is focused on will provide tools to solve further 
research questions about the ClpXP adaptor hierarchy. I will discuss the lessons 
and perspectives about adaptors and adaptor-mediated protein degradation that I 
have gathered throughout my Ph.D. and its impact to the adaptor field. Finally, I 
will discuss future avenues of research that are of particular interest to me and 












4.2 Impact of Thesis Work on Protease Adaptor Field 
My thesis built on the work and the fundamental observation that adaptors can 
work synergistically to provide additional layers of regulation to protein 
degradation during critical cellular stages of growth and development (Joshi et 
al., 2015). Furthermore, my thesis work expanded on the initial observation that 
when an adaptor protein is not actively performing its delivery function, it is 
actively degraded by the protease (Joshi et al., 2017). However, these 
observations did not fully explain how each of the adaptors serve their regulatory 
role and why adaptor degradation matters in vivo. The composite work of my 
mechanistic studies of RcdA and PopA demonstrates that in addition to the basic 
function of an adaptor choosing specific substrates by acting as a scaffold, cell-
cycle specific adaptors such as RcdA and PopA possess additional layers of 
regulation that are needed to tune the activity levels of each adaptor during the 
cell-cycle, and in the case of RcdA, this additional layer of regulation also 
controls its proteolytic stability. RcdA’s regulation of activity and degradation is 
linked through dimerization by acting as an inhibitory role against prolific RcdA 
activity. The work presented in Chapter 2 was the first demonstration of adaptor 
dimerization having a direct consequence on its stability and this stabilization 
having a physiological consequence, as adaptor degradation has been observed 
in other bacteria (Puri et al., 2017, Turgay et al., 1998) but not elaborated upon. 
This piece of information can perhaps lend itself to future studies of adaptor 




determinants of adaptor degradation, modifying those determinants, and looking 
for changes in cell viability or physiology. Perhaps even more fascinating 
concerning adaptor degradation in Caulobacter crescentus is that PopA does not 
get degraded, while CpdR and RcdA are degraded robustly (Joshi et al., 2017). 
What properties about PopA prevent its self-degradation that CpdR and RcdA do 
not have, and why is PopA not found in every organism that contains CtrA, such 
as Brucella abortus? A possible explanation is that the constitutive presence of 
PopA is necessary for proper timing of the delivery of CtrA during the cell-cycle, 
while for CpdR and RcdA and their respective substrates this is not a 
requirement. Further studies elaborating on the specifics of CpdR degradation 
and consequentially their effects on cell viability and substrate delivery would 
help clarify the overall significance of adaptor degradation not only in 
Caulobacter, but in all organisms that use adaptors as protease regulators. The 
specific studies needed for RcdA characterization might not generalize to other 
adaptors and for me, personally, this is an aspect of adaptors that should be 
explored further in the field to really understand the significance of adaptors in 
maintaining cell physiology. These types of studies would lend themselves well in 
organisms such as Caulobacter that have distinct developmental transitions or 
stress responses that are aided by adaptor-mediated protein degradation.  
The finding that RcdA reserves different aspects of its dimerization interface for 
different cargo provides further understanding for how an adaptor that has a pool 




a common interface, specificity is achieved by tailoring different aspects of the 
interface to different classes of cargo. The RcdA pulldown data (Joshi et al., 
2015) suggested a large range of otherwise uncharacterized RcdA interacting 
partners. It is possible that RcdA represents a general adaptor specifically 
evolved to fulfill the role of delivering dozens of substrates during the cell-cycle 
that have no shared similarities, functions, or structures. In this case, the 
experimental approaches outlined in Chapter 2 would help identify the overlap 
between different classes of cargo: some cargo might interact at the SpbR/TacA 
site, while others might interact at the PopA site, including as-of-yet to be 
discovered adaptor proteins. Using mutants such as the RcdA L82E or RcdA 3E 
could be used to filter out false positives. For organisms that undergo specific 
developmental transitions that are accompanied by coordinated protein 
degradation by adaptors, having a general adaptor that can degrade several 
classes of cargo such as RcdA allows the cell to preserve energy by not requiring 
many different adaptors to be synthesized. Other bacteria that undergo 
morphological differentiation that is dependent on protein degradation might 
make use of an adaptor that contains a large interface that is tailored to 
accommodate different varieties of cargo. In contrast, bacteria that do not 
undergo distinct morphological transitions during their life cycle, such as E. coli, 
use adaptors such as SspB and RssB have a limited range of cargo in 
comparison to RcdA. The use of a smaller, more specific interaction site fits the 




PopA represents a different adaptor than RcdA in that its delivery activity is 
regulated by a small molecule, rather than oligomerization. It was hinted that 
PopA dimerization might be important in vivo (Wang et al., 2021). However, the 
data presented in Chapter 3 suggests that binding of cdG to PopA allows for 
conformational changes in PopA to accommodate CtrA binding and delivery 
independent of PopA dimerization, as concentrations of PopA and cdG that 
promote full delivery and binding of CtrA do not induce dimerization. Binding of 
cdG accomplishes the same purpose of the dimer interface of RcdA: to gate CtrA 
delivery activity of PopA only when it is necessary. For the adaptors in the ClpXP 
adaptor hierarchy, an additional layer of regulation for each adaptor is present, 
whether it is phosphorylation of CpdR, dimerization of RcdA, or cdG binding to 
PopA. Each adaptor in the hierarchy is mechanistically and structurally diverse 
from each other, yet a need exists for gated activity because of the role each 
adaptor plays in the Caulobacter cell cycle. One interesting fact is that PopA 
does not exist in other bacteria and is only present in closely related 
alphaproteobacteria to Caulobacter (Brilli et al., 2010). However, 
alphaproteobacteria such as Sinorhizobium meliloti and Brucella abortus contain 
the CtrA gene network (including CpdR and RcdA) yet do not possess PopA. In 
the case of Sinorhizobium meliloti, the proteolysis of CtrA is essential for proper 
cell morphology and this proteolysis is dependent on CpdR and RcdA and 
perhaps an unknown adaptor that fulfills the role of PopA (Pini, et al 2015). My 




CtrA will hopefully develop a template for how an unknown adaptor that is 
necessary for CtrA degradation might function in other organisms. This would 
potentially lend itself well to a screen for RcdA and CtrA binders, as the 
interaction surfaces and specific folds PopA adopts might be similarly evolved in 
a different protein to serve the same function for CtrA degradation. 
 
My thesis provides insight into how adaptor activities can be gated by additional 
layers of regulation, depending on the need for the adaptor in the cell. My 
specific studies of PopA and RcdA identify key characteristics of each adaptor 
that are critical to its function and provide a framework for how the basic 
interactions and determinants between RcdA and PopA might function in other 
organisms. The future of the adaptor field will likely be influenced by the 
development of genetic and proteomic screens to reliably identify new adaptor-
substrate pairs that regulate critical stress responses and developmental 
transitions in pathogenic bacteria to identify which adaptors could be targeted as 
avenues for antibiotic drug discovery. The remainder of this chapter will discuss 










4.3 CryoEM characterization of the ClpXP Adaptor Hierarchy 
Recent Cryo-EM structures of the ClpXP machinery have uncovered critical 
information regarding the fundamental mechanism of ClpXP activation and 
substrate interactions (Gatsogiannis et al., 2019, Fei et al., 2020, Bell et al., 
2020). However, these CryoEM studies were limited to variants of ClpX lacking 
the N-terminal domain, the part of ClpX that is necessary for CpdR interactions 
and adaptor-mediated protein degradation (Lau et al., 2015). Therefore, 
mechanistic insight into how the adaptor hierarchy structural forms and performs 
its function is sorely lacking as of now. During my Ph.D., I was part of a 3-year 
collaboration with Gabe Lander’s lab to solve CryoEM structures of the adaptor 
hierarchy. Unfortunately, we have not been able to solve the CryoEM structure of 
any of portion of the adaptor hierarchy that involves ClpX with its N-terminal 
domain intact and in the presence of other adaptors. While we made progress in 
forming stable adaptor-protease complexes suitable for CryoEM analysis, more 
work is necessary to produce enough of these ternary complexes for CryoEM. 
Even a CryoEM structure of native ClpXP bound to CpdR would inform a great 
deal on the composite interface that is hypothesized to be necessary for CpdR-
mediated degradation (Lau et al., 2015). Furthermore, a native CryoEM structure 
of ClpXP with adaptors bound will help explain how any potential avidity effects 
help aid in degradation. For the case of RcdA, my thesis work and the previous 




degradation in detail, but do not fully explain why all these adaptors are 
necessary for recruiting their substrates for ClpX recognition and degradation. An 
atomic snapshot of ClpXP with CpdR, RcdA and their respective cargo would 
elucidate how the adaptor hierarchy accomplishes this handoff and the 
interactions that facilitate this sequence of events. The primary challenge is 
obtaining stable, highly concentrated Adaptor-bound complexes needed for 
CryoEM. Chemical crosslinking and using a small SEC column that prevents 
dilution, along with more optimized purification protocols for ClpX to increase 
yield, are necessary to move this project forward. The concentration of  is the 
limiting factor in getting high quality samples, as ClpP, CpdR, and RcdA are all 
very soluble at high concentrations, while concentration of ClpX results in drastic 
loss of protein in a spin concentrator. Using different expression systems and 
purification schemes to increase ClpX yield would speed up preparing highly 
soluble, concentrated samples necessary for CryoEM. The value of having such 
a CryoEM structure would answer questions about how the delivery mechanism 
of an adaptor-mediated substrate, such as PdeA, TacA or SpbR, is determined 
by the collective interactions between adaptors and protease. 
4.4 Structural characterization of RcdA-Cargo Interactions 
My HDX-MS studies highlighted two surfaces that, by mutagenesis, were 
mutually exclusive for direct RcdA cargo and other adaptors like PopA. However, 
due to the limited resolution of HDX, we cannot assign atomic-level information 




causes RcdA to dissociate into monomers, a crystal structure of RcdA bound to 
cargo is needed. In the past, we have tried to crystallize RcdA bound to SpbR 
and TacA as a co-crystal complex, but that came with its own issues. The RcdA 
homodimer appears to crystallize more readily than the RcdA-cargo complex, 
and the binding affinities of dimerization and cargo binding are similar, making 
crystallization of native RcdA-cargo complexes challenging. Because the L82E 
variant does not dimerize and can bind PopA with affinities like native RcdA, a 
viable approach would be to solve a structure of L82E bound to PopA or bound 
to the receiver domains responsible for interacting with RcdA. Furthermore, NMR 
structures of the L82E variant bound to the receiver domains of PopA might be a 
viable approach for mapping RcdA-cargo interactions at the atomic level.  
4.5 Mechanistic Characterization of CpdR Function 
CpdR is responsible for the regulated degradation of all known cell-cycle 
dependent ClpXP substrates (Lau et al., 2015). The biological consequences of 
mis regulation of CpdR function are distinct, causing motility defects and loss of 
ClpX localization to the cell poles (Lau et al., 2015). While it seems clear that 
CpdR must prime ClpX for degradation of its substrates, mechanistic 
characterization of these interactions and how this specificity is achieved remains 
unclear. Several remaining questions and obvious experiments could possibly 
shed insight into this question. It seems clear that the interaction of CpdR and 
ClpX is necessary for degrading CpdR-dependent substrates. How does this 




using purified proteins or a linked complex with native ClpX or just the NTD, 
would help explain this observation. Furthermore, NMR studies of CpdR bound 
the NTD would help identify the interface that CpdR binds to. Mutagenesis of 
residues that are identified in these datasets would help confirm these interfaces. 
Finally, limited proteolysis of a linked CpdR-NTDClpX or even a linked RcdA-
CpdR-NTDClpX complex could also be an approach to identify regions that are 
more resistant to proteolysis, suggesting protein-protein interaction surfaces. ITC 
or Fluorescence Polarization studies of CpdR-NTDClpX would help aid in these 
studies to determine binding affinities and stoichiometries. CpdR could also be 
negatively regulated by dimerization through an active, unphosphorylated 
conformation. In this model, phosphorylation of CpdR leads to dimerization and 
inhibition of CpdR activity. Interestingly, The D9G mutant appears to form less 
higher-molecular weight aggregates during SEC purification (Christine Battle, 
unpublished data), suggesting that this variant may have differences in 
oligomerization. SEC-MALS or AUC using the D9G variant, a 
nonphosphorylatable CpdR variant (CpdR D51A) or using native CpdR in the 
presence of the phosphorelay system might help elucidate this mechanism of 
activation by dimerization.  
4.6 Identification of New Adaptor-Dependent Substrates and Pathways 
Discovery of new adaptors and adaptor-substrates pairs is a circular problem. 
We identify adaptor function by showing enhanced degradation of a substrate, 




TacA and PdeA, prior knowledge from a ClpP trapping experiment identified 
these proteins as ClpXP substrates prior to our labs discoveries as CpdR and 
RcdA as their respective adaptors (Bhat et al., 2013). Biochemical reconstitution 
of these adaptor-substrate pairs confirmed the enhancement of PdeA and TacA 
degradation (Lau et al., 2015, Joshi et al., 2015). However, more systematic 
approaches for identifying new adaptor-substrate pairs are needed. Our labs 
recent optimization of systems biology approaches such as Transposon 
Sequencing (Tn-seq) and Tandem Mass Tag Proteomics (TMT) will provide a 
roadmap to developing methods for identifying new adaptor-substrate pairs and 
adaptor-dependent pathways. For example, particular adaptor variants that 
change adaptor function (such as RcdA L82E, RcdA 3E, CpdR H106A, CpdR 
R69A, PopA R357G) all contain specific changes in their activity that result in 
specific changes in substrate delivery and morphology. Along with adaptor 
deficient strains (ΔcpdR, ΔrcdA, ΔpopA), making strains containing these 
mutations would allow for optimal controls for identifying changes in our adaptor 
deficient strains, as we know that RcdA L82E and RcdA 3E contain substrate 
binding deficiencies, and PopA R357G cannot deliver CtrA during the cell cycle 
due to loss of cdG binding (Duerig et al., 2009). For example, to identify a 
potential new RcdA binding partner, deletion of RcdA show result in an increase 
in protein abundance of a particular candidate by TMT. If the RcdA L82E showed 
no change in that substrate’s abundance, but the RcdA 3E showed a relative 




the abundance of that substrate are due to RcdA binding at the surface 
implicated in PopA binding and it would make it much easier to identify highly 
specific RcdA binders. The same approach could be used for CpdR and PopA to 
identify new substrates by TMT. Identifying new adaptor-dependent pathways 
could follow a similar roadmap: adaptor deficient strains will likely see changes in 
the insertion profile of many substrates. If that insertion profile is differentially 
affected in one RcdA variant versus another, then it could be concluded that 
RcdA is involved in this pathway. If it is found that upon purification of candidates 
that show a change in insertions are not enhanced in their degradation upon 
addition of adaptor, then a potential novel role for an adaptor in that pathway 
independent of enhancing proteolysis could be hypothesized. The use of adaptor 
variants could potentially help weed out potential false positives amid the large 
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Figure A.4: The RcdA R131/5E Variant is Dimeric 
SEC-MALS analysis of the R131/5E variant compared to WT RcdA. Both proteins 
were run over the column at 25uM. Dotted lines indicated collected MALS data 
and calculated mass. The R131/5E mutant was designed to disrupt the 
crystallographic dimer interface of our in-house solved crystal structure of RcdA, 
but that interface was shown to be the incorrect interface. The dimer interface 
















Figure A.5: The RcdA L82A Variant is Dimeric 
SEC-MALS analysis of the L82A variant compared to WT RcdA and RcdA L82E 
(RcdA and L82E SEC-MALS Data is from Figure 2.10). Dotted lines indicated 
collected MALS data and calculated mass. The L82A variant did not scatter light 
in this experiment, but coeluted perfectly with WT RcdA, suggesting dimerization. 
The L82A mutant was designed to test whether we could form an obligate 
monomer of RcdA that did not affect cargo binding or delivery. This data tells us 
that the presence of L82 is not necessary for dimerization, as mutation to another 














Figure A.6: RcdA Monomerization is Not Detectable by SEC-MALS 
Serial Dilutions of RcdA were ran over the SEC-MALS column. At the 
concentrations detectable by absorbance, RcdA monomerization was not able to 
be determined by SEC-MALS. This describes a key limitation to SEC-MALS: the 
light scattering signal is proportional to the concentration of your injected protein, 
it becomes challenging for proteins of smaller mass to design SEC-MALS 























Figure A.7: RcdA Monomerization is Not Detectable by SV-AUC 
Different concentrations of RcdA were ran on the analytical centrifuge and 
analyzed by sedimentation velocity. At the concentrations detectable by 
absorbance, an RcdA monomer-dimer equilibrium was not observed in the c(s) 
distributions provided by SV-AUC. Since we could not detect RcdA 
monomerization by absorbance detection, we decided to use a fluorescent reporter 
(Fluorecin-5-maleimide RcdA) and isothermal titration calorimetry to monitor RcdA 
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Figure A.8: HSQC NMR Spectrum of RcdA-DBDTacA interaction 
Early in my graduate career, we collaborated with the Strieter lab to perform protein 
NMR studies (Lin Hui, Eric Strieter) to see if we could possibly elucidate the binding 
site of RcdA to DBDTacA. While we did see changes in the peak assignments when 
DBDTacA was added (inset), we were unable to determine the final binding site. 
Repeating this experiment with the RcdA L82E variant with PopA truncations 









































Figure A.9: Schrodinger-Modeling TacA Peptide on RcdA Crystal Structure 
The original identification of the RcdA 3E residues was through Schrodinger 
modeling (collaboration with Sergey Savinov) of a TacA peptide on our in-house 
solved structure of RcdA, which revealed a “pocket” that was proposed as 
important for ligand binding. In purple is the modeling TacA peptide, while in red 
sticks are the residues of the RcdA 3E mutant: R49, K53, R57. These residues 
were mutated to glutamic acids by Ashley Kosowicz, a previous undergraduate in 





































Figure A.10: Intrinsic Tryptophan Fluorescence Scans of RcdA and RcdA 
L82E 
Intrinsic Tryptophan Fluorescence Profiles of RcdA and RcdA L82E in the absence 
or presence of denaturant (5M Guanidine Hydrochloride). In the presence of 
GuHCL, both RcdA and RcdA L82E shift in λmax (330nm to 350nm), indicating the 
unfolding of the protein. Interestingly, upon unfolding, the fluorescence of RcdA 
L82E increases relative to the native state, while the fluorescence of RcdA 
decreases relative to the native state. The intrinsic tryptophan fluorescence per 
monomeric concentration unit of RcdA L82E is lower than that of RcdA at equal 





















Figure A.11: The RcdA 3E Variant does not form a Heterodimer by 
Fluorescence Polarization 
Fluorescence polarization looking at heterodimerization of fluorescently-labeled 
RcdA with unlabeled RcdA variants. Assays were performed exactly as described 
earlier, with 20uM of unlabeled RcdA 3E, RcdA 131/5E, PopA and RcdA added to 
100nM labeled RcdA. The only variant to not show an increase in polarization was 
the RcdA 3E variant, which did not show a characteristic increase in polarization 



















Figure A.12: Differential Scanning Fluorimetry Melt Curves of RcdA 
Variants 
DSF melt curves of various RcdA variants at 10uM final concentration. Melt curves 
were generated as described in appendix methods. Fitted Tm values are listed 
above the dotted line for each variant. The RcdA 3E and RcdA R131/5E variants 
are destabilized relative to WT RcdA as observed by their lower Tm values. 
Interestingly, the RcdA L82E monomer did not produce a melt curve or show a 
steady increase in fluorescence as the protein was heated, indicating that the 
















Figure A.13: ITC Thermogram of L82E-PopA Interaction 
ITC Thermogram of 400µM L82E titrated into a pool of 40µM PopA. Both proteins 
were purified into 20mM Hepes, pH 8.5, 100mM KCL over an S200 size-exclusion 
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Figure A.14: GFP-DBDTacA Assays in the Presence of PopA-RD1 truncation 
(aa 1-117) 
GFP-DBDTacA fluorescence degradation assay in the presence of different 
concentrations of PopA-RD1. 1µM GFP-DBDTacA 1µM RcdA, 4µM CpdR, 0.2µM 














Figure A.15: CpdR-ClpX Binding Curves with L82E and RcdA Fluorescent 
Reporters 
ClpX-CpdR interactions using a fluorescent RcdA or RcdA L82E Reporter. 1µM 
ClpX, 1mM ATPyS, 100nM FL-L82E or RcdA and varying concentrations were 
used. A single site binding model was used to fit the data in prism as outlined in 


















Figure A.16: CpdR Kactivation Curve with GFP-DBDTacA 
GFP-TacADBD fluorescence degradation assay in the presence of different 
concentrations of CpdR. 1µM GFP-DBDTacA, 1µM RcdA, 0.2µM ClpX, 0.4µM ClpP, 
and varying concentrations of CpdR were used in this assay. Data was fit to a 
modified form of the Michaelis-Menten equation as noted in the methods of 









Additional In Vivo Data 
Figure A.17: Agar Motility Assay of PrcdA::L82E and PrcdA::RcdADD, related 
to data presented in Figure 2.28   
While generating the PrcdA::L82E strain, we looked for phenotypes that might be 
used to screen for positive mutants.  ince we know that ΔrcdA strains have a 
motility defect, we used motility as a readout of positive strain construction. 
Interestingly, the PrcdA::L82E has a defect in motility while the PrcdA::RcdA and 
PrcdA::RcdADD strains do not have motility defects, suggesting that the motiltity 
phenotype is likely linked to deficiencies in cargo delivery due to the L82E 






Figure A.18: CtrA Synchrony assay of PrcdA::RcdADD 
Before we generated the PrcdA::L82E strain, we hypothesized that RcdADD might 
deliver substrates faster in vivo because of its prolonged time on the CpdR-ClpX 
complex due to its inability to be degraded. The PrcdA::RcdADD strain was capable 
of delivering CtrA to ClpXP more quickly throughout the cell cycle. Shown on the 
left is a representative western blot of this timecourse and on the right is the 






















































Figure A.19: PrcdA::RcdADD Competition Fitness Assay 
Fitness competition assay between wildtype and PrcdA::RcdA or PrcdA::RcdADD. 
Like Figure 2.28D, the wildtype and ΔrcdA data are the same controls used. 
Average and standard deviation of three independent replicates is shown. 











Figure A.20: Phosphomyocin Spot Assay of Adaptor Deficient Strains 
Upon characterization of RcdA-dependent phenotypes, we found that addition of 
the cell wall stressor that targets MurA, Phosphomyocin, caused viability defects 
on an agar plate. Shown is a spot assay of ΔrcdA and ΔpopA strains on PYE and 
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